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 One area of research in the field of Autism Spectrum Disorders (ASDs) involves efforts 
to better understand symptom manifestation at earlier points in an individual’s life. Researchers 
have consistently emphasized the importance of early intervention for children with an ASD, but 
the determination of the most efficacious treatment approach is often established on a case-by-
case basis by taking into consideration an individual’s specific needs. The need for such 
individualized treatment approaches is accentuated by the high prevalence of comorbid 
psychopathology within the ASD population. The study of comorbid disorders among young 
children with ASDs has been hindered by a lack of measures normed for an ASD population, 
until recently. The development of the Baby and Infant Screen for Children with aUtIsm Traits-
Part 2 (BISCUIT-Part 2) assessment battery has provided clinicians with an empirically derived 
scale designed to assess comorbid psychopathology in young children with ASDs or atypical 
development. The aim of the present study was to examine the diagnostic and temporal 
influences on comorbid psychopathology symptoms in infants and toddlers with ASD.  
Participants were separated into one of three groups based on their diagnoses (i.e., Autistic 
Disorder [AD], Pervasive Developmental Disorder-Not Otherwise Specified [PDD-NOS], and 
atypical development without an ASD). Children were assessed with the BISCUIT-Part 2 twice, 
with the initial and follow up assessment occurring within one of two time intervals; 4 to 8 
months, or 9 to 13 months. Results from the current study indicate that children diagnosed with 
AD exhibit significantly less stable symptoms of comorbid psychopathology. Further, the time 
between initial and follow up assessments is a significant factor influencing symptom 







Autism Spectrum Disorders (ASDs) are a severe and lifelong set of neurodevelopmental 
disorders (Rivet & Matson, 2011; Weinkauf, Zeug, Anderson, & Ala’i-Rosales, 2011). In 
support of the neurodevelopmental origins, McPartland, Coffman, and Pelphrey (2011) have 
presented research showing that irregular activity in the brain regions associated with social 
interactions (i.e., mirror neurons) may act as a possible genetic marker for ASDs.  The presence 
of ASD is often recognized based upon abnormalities in three core areas: social interaction, 
communication skills, and restricted and repetitive behaviors (Rivet & Matson, 2011; Weinkauf, 
Zeug, Anderson, & Ala’i-Rosales, 2011; Xianchen, Hubbard, Fabes, & Adam, 2006). In addition 
to these core symptoms, concomitant psychopathology and challenging behaviors are often 
present (Bakken et al., 2010; Davis et al., 2011; Funabiki, Kawagishi, Uwatoko, Yoshimura, & 
Murai, 2011; Horovitz et al., 2011). 
Traditionally, diagnosticians have disregarded formulations of comorbid psychiatric 
disorders for individuals with ASD (Lainhart, 1999). This diagnostic indifference has been 
attributed to many factors. The unique manifestation of psychopathological symptoms when an 
ASD is present makes differential diagnosis increasingly more difficult (Gillberg, 2010). Rutter 
(1968) also highlighted the relative lack of agreed upon diagnostic criteria for an ASD diagnosis 
as a contributing factor. However, due to the mounting evidence investigators have found 
supporting the presence of co-occurring conditions and their subsequent impact (Bakken et al., 
2010; Gillberg, 2010; LoVullo & Matson, 2009; Matson & Minshawi, 2006; Matson & Nebel-
Schwalm, 2007), the controversy regarding comorbid psychopathologies within ASDs has 
largely been quelled. Challenging behaviors and psychopathology have consistently been 





(Barthélémy et al., 1992; Dawson, Matson, & Cherry, 1998; Holden & Gitlesen, 2007; Matson & 
Nebel-Schwalm, 2007; Paclawskyj, Matson, Bamburg, & Baglio 1997).  
The addition of a comorbid psychiatric condition to individuals with an ASD diagnosis 
necessitates the need for highly individualized interventions (LoVullo & Matson, 2009). For 
example, while a behavioral intervention may be used to address symptoms of ASD, alternative 
intervention techniques (e.g., psychotropic medication) may be necessary for some comorbid 
disorders (LoVullo & Matson, 2009; Self, Hale, & Crumrine, 2010). Comorbid conditions can 
often further complicate the diagnostic process and treatment plan, which often adversely affects 
not only the individual, but those involved in the provision of care as well (Gray, Ansell, Baird, 
& Parr 2011; Matson & Minshawi, 2007; Matson & Nebel-Schwalm, 2007).   
While the need for early intervention has been recognized, there are currently few 
existing comorbid psychopathology assessments normed for the ASD population.  This dearth of 
appropriate assessment tools contributes to the lack of understanding researchers, clinicians, and 
parents have regarding co-occurring conditions in children with ASDs (Matson et al., 2010).  
The use of traditional assessments (i.e., assessments used in the typically developing population) 
to investigate and diagnose the presence of comorbid psychopathologies in individuals with 
ASDs is insufficient due to the additive complexity in behavioral presentation (Matson et al., 
2007). Fortunately, the recent development of the Baby and Infant Screen for Children with 
aUtIsm Traits-Part 2 (BISCUIT-Part 2) has provided an empirically validated assessment of 
comorbid psychopathology in young children with ASD and atypical development (Matson, 
Boisjoli, Hess, & Wilkins, 2011). In the current study the researcher utilized the BISCUIT-Part 2 





diagnostic and temporal influences on symptom expression. Symptoms will be considered 
“stable” if they do not differ significantly between the initial and follow up assessment periods. 
Symptoms of psychopathology were assessed across two administrations of the 
BISCUIT-Part 2. The same parents/caregivers of the infants and toddlers served as informants 
each time as part of their participation in Louisiana’s EarlySteps Program. Symptom stability 
was compared across participants falling into one of three diagnostic categories (i.e., Autistic 
Disorder [AD], Pervasive Developmental Disorder – Not Otherwise Specified [PDD-NOS], and 
atypically developing without an ASD) in order to determine if diagnosis significantly predicts 
concomitant psychopathological expression. Additionally, temporal influences were examined 
for each diagnostic category by inspecting the time interval between initial and follow up 
assessment (i.e., 4 to 8 months, and 9 to 13 months). The history of ASDs, research on comorbid 
psychopathology, and assessment techniques for this population are reviewed, followed by 





HISTORY OF AUTISM SPECTRUM DISORDERS  
 
 In 1943, Leo Kanner published the seminal article “Autistic Disturbances of Affective 
Contact.” He introduced a new type of developmental disorder, which is now commonly referred 
to as autism. Kanner’s (1943) original article contained the descriptions of 11 children (i.e., eight 
males and three females) ranging from 2 to 8 years of age. Each child presented with similar 
symptomology which failed to explicitly meet any current diagnostic criteria. Though some 
variation in appearance and severity was evident, the children all exhibited three core deficits, 
discrepancies in language use and acquisition, insistence on sameness and stereotypic behavior, 
and failure to relate to others and form proper social relationships. Van Krevelen (1971) and 
Rutter (1978) later published research replicating these three core deficits, which were 
popularized by Wing and Gould (1979) who referred to these deficits as the “autism triad.”  
 The term “autism,” itself, was not new to the field of psychology and was actually coined 
in 1908, by Swiss psychiatrist, Eugene Bleuler (as cited in Fusar-Poli & Politi, 2008). Notably, 
Bleuler did not introduce the term as nomenclature for a new neurodevelopmental disorder (as 
cited in Fusar-Poli & Politi, 2008).  Instead, he used the term to label, what he considered a core 
feature of schizophrenia: “turning away from reality, sees life in fantastic pictures, and is 
founded precisely upon autistic thinking.” (Bleuler, 1913, p. 874). Kanner, however, utilized the 
term “autism” to specifically describe an individual’s inability to relate to themselves and others, 
which he described as “extreme autistic aloneness” (Kanner, 1943, 1944). This overlap in 
terminology created persistent diagnostic problems and turmoil amongst clinicians in the area of 
differential diagnosis.   
Kanner noted in his observations that clinicians most often described the children 





diagnostic overlap can be attributed to the childhood schizophrenia definition proposed by 
Despert (1938), “ a disease process in which the loss of affective contact with reality is 
coincident with or determined by the appearance of autistic thinking and accompanied by 
specific phenomena of regression and dissociation.” (p. 366).  Kanner, however, disagreed with 
the diagnostic confusion and emphasized that “these characteristics form a unique syndrome, not 
heretofore reported, which seems to be rare enough, yet is probably more frequent than is 
indicated due to the paucity of observed cases” (Kanner, 1943, P. 242). In an attempt to 
distinguish this new neurodevelopmental disorder from childhood schizophrenia, Kanner (1944) 
proposed to rename it “early infantile autism.” 
 Kanner’s utilization of the term “autism” undoubtedly contributed to the general lack of 
diagnostic differentiation, and consequently served as the topic of much discussion in the 
literature of the period (Rutter, 1972a, 1978; Volkmar & Klin, 2005).  During this period, 
clinicians freely interchanged diagnoses of childhood schizophrenia, autism, and childhood 
psychosis (Laufer & Gair, 1969; Rutter, 1978).  Eisenburg (1966) noted the direct negative 
impact that terminology confusion had on the ASD population and associated research, as many 
clinicians and researchers struggled to distinguish autism and childhood schizophrenia (Matson 
& Minshawi, 2006). The lack of differential diagnosis may be further attributed to the diagnostic 
measures developed during this period which only sought to identify the presence of psychosis, 
not a particular syndrome (Prior & Bence, 1975). 
 Similarly, early diagnostic manuals failed to differentiate ASD from childhood 
schizophrenia. Childhood schizophrenia was the only official term available in the first and 
second editions of the Diagnostic and Statistical Manual of Mental Disorders (American 





autistic features. When AD first debuted in the World Health Organization’s (WHO) 
International Classification of Diseases, 8
th
 Revision (ICD-8; 1967), it appeared as “infantile 
autism,” a sub-type of schizophrenia, and lacked any specified criteria. In the ICD-8 Glossary 
and Guide, autism was classified under “behaviour disorders of childhood” (WHO, 1974). Later, 
autism was later re-categorized as “psychoses with origin specific to childhood” within the ICD-
9 and subsequent Glossary and Guide (WHO, 1977, 1978). 
The changing terminology was not without influence upon researchers. Diagnostic 
confusion led some researchers to suggest terminology that pointed to potential causes of the 
disorder. For example, Rutter and colleagues (1969) suggested the use of the provisional 
terminology “disintegrative psychosis” to describe the period of profound regression in children 
around the age of 4 that was considered distinct from both schizophrenia and infantile autism. 
Van Krevelen (1971) sought to utilize the term “autismus infantum,” suggesting cerebral 
disorders as the causal agent of infantile autism. 
Diagnostic Development 
 Following Kanner and Asperger’s original works, research interests expanded 
exponentially and created a divide amongst researchers. Some researchers sought to differentiate 
ASDs from childhood schizophrenia, while others produced studies attempting to highlight their 
similarities.  Significant research contributions by Rutter (1968, 1972b, 1978), highlighted the 
differences between autism and childhood schizophrenia. For example, Rutter (1978) 
differentiated ASD from childhood schizophrenia by suggesting ASD had a 4:1 (male to female) 
gender ratio, while suggesting the gender ratio in childhood schizophrenia is generally 
recognized as being equal.  Rutter (1972b, 1978) also showed that in direct contrast with 





include impaired intellectual function when compared to typically developing peers, stability of 
presenting symptomology, and earlier onset. In conjunction with his efforts to distinguish ASDs 
from childhood schizophrenia, Rutter and colleagues (1969) also sought to identify clear 
diagnostic criteria to diagnose autism. 
 Two important distinctions would ultimately differentiate ASD and childhood 
schizophrenia. The identification of a period of marked “regression” and the age criteria (i.e., 13) 
identified by Despert (1938) in childhood schizophrenia directly contended with the clear and 
evident deficit from birth seen in autism (Kanner, 1943; Rutter, 1978). However, in actuality, it 
would be more than thirty years from the original observations before childhood schizophrenia 
and autism were diagnostically distinguished (Volkmar, Klin, & Cohen, 1997).  This feat only 
occurred with the introduction of the “Pervasive Developmental Disorders” (PDDs) category, 
which was included in the 1980 release of Diagnostic and Statistical Manual of Mental 
Disorders, 3
rd
 Edition (DSM-III; APA). The terms “PDD” and “ASD” are used interchangeably 
in current research articles; however, the current paper will utilize only “ASD” henceforth 
(Baird, Cass, & Slonims, 2003).  
The ASD category is an umbrella term encompassing the varied degrees of 
symptomology observed across the lifespan. Upon its introduction, ASD included five separate 
disorders: infantile autism, residual infantile autism, childhood onset pervasive developmental 
disorders, residual child-onset PDD, and atypical pervasive developmental disorder (Volkmar & 
Klin, 2005). For the first time, the diagnostic criteria for each ASD presented in the DSM-III 
were based on empirical research (Volkmar & Klin, 2005).  DSM-III also employed a multi-axial 
diagnostic approach, simultaneously accounting for symptom severity by identifying specific 





The introduction of ASDs in the DSM-III encouraged researchers  to explore these 
disorders further, and as data and knowledge grew, so did the discrepancies surrounding 
diagnostic criteria. Based on supporting research, the APA sought to clarify the diagnostic 
criteria along with other issues in the 1987 release of the Diagnostic and Statistical Manual of 
Mental Disorders, 3
rd
 edition-revised (DSM-III-R). The DSM-III-R reduced the number of ASD 
diagnoses by completely removing infantile autism, residual infantile autism, and childhood 
onset pervasive developmental disorders, replacing them with AD and PDD-NOS (Waterhouse, 
Wing, Spitzer, & Siegel, 1989). A second significant change was the removal of the specified 
age of onset for AD (i.e., onset prior to 30 months; Waterhouse et al., 1989). Waterhouse, Wing, 
Spitzer, and Siegel (1989) also noted the additional establishment of diagnostic boundaries for 
considering comorbid diagnoses.   
Despite the progression and changes mentioned, it is notable that no version of the DSM 
had yet sought to include the syndrome that Hans Asperger discovered. Only a year after 
Kanner’s seminal 1943 article, Asperger wrote his thesis “Autistic Psychopathy in Childhood” 
(Asperger & Frith, 1991).  Written in German, Asperger’s thesis remained largely undiscovered 
by the scientific community until it was eventually translated into English forty-seven years later 
by Uta Frith. The thesis outlined the profiles of four children who expressed symptoms similar to 
those seen in autism, but with a later age of onset, and “pedantric patterns of speech” (Asperger 
& Frith, 1991). Asperger’s Syndrome (AS) did not appear in a diagnostic manual until its 
inclusion in the International Classification of Diseases, 10
th
 Edition (ICD-10), which was 
released by the WHO in 1992. In addition to AS, the ICD-10 incorporated multiple ASDs; 
atypical autism, disintegrative disorder, Rhett’s syndrome, and overactive disorder with mental 





diverse clinical features and varied degrees of severity as reasoning to include such a large 
number of diagnoses within the ASD umbrella. The diversified presentation of clinical features 
within the autism spectrum was also acknowledged in the Diagnostic and Statistical Manual of 
Mental Disorders, 4
th
 Edition (DSM-IV; APA, 1994) and DSM-IV-Text Revision (DSM-IV-TR; 
APA, 2000).  
Presently, five disorders comprise the ASD category, AD, AS, Rhett’s Disorder, 
Childhood Disintegrative Disorder, and PDD-NOS (APA, 1994, 2000; Lecavalier, Gadow, 
DeVincent, Houts, & Edwards, 2009). In addition to categorical changes, the DSM-IV also 
implemented criteria changes such as the reestablishment of an age of onset criteria for AD of 36 
months (APA, 1994; Volkmar & Klin, 2005). To address the variance of symptom presentation, 
the DSM-IV task force established separate criteria for each ASD category, with the exception of 
PDD-NOS. The ASD diagnoses were arranged hierarchically so that AD required a minimum of 
six criteria for diagnosis, and an AS diagnosis was considered only after AD was ruled out and 
three criteria were met (Mandy, Charman, Gilmour, & Skuse, 2011). The PDD-NOS diagnosis 
resides at the bottom of the hierarchal model, and was included to capture individuals that failed 
to meet the specified criterion for a specific ASD, but still warranted an ASD diagnosis (e.g., 
sub-threshold symptoms, late onset; Mandy et al., 2011). The WHO (1992) collaborated with the 
APA’s DSM-IV task force to ensure that the criteria they established would be in close alignment 
with those set forth by their release of the ICD-10.  
Although ASDs encompass five distinct disorders, the present study will only examine 
AD and PDD-NOS due to limited data and insufficient diagnostic reliability within the toddler 
age group for the latter three ASDs (i.e., AS, Childhood Disintegrative Disorder, and Rhett’s 





González, & Wilkins, 2009; Schopler, Reichler, Devellis, & Daly, 1980). Therefore, only AD 
and PDD-NOS will constitute the ASD category when mentioned henceforth (Matson et al., 
2008; Worley, Matson, Mahan, Kozlowski, & Neal, 2011). 
Differential Diagnosis 
Defining and diagnosing ASDs has advanced considerably over time leading to a better 
understanding of the presenting symptoms and features. However, Baird, Slonims, and Cass 
(2003) suggested that differential diagnosis remains problematic due to the variance of 
presenting symptomology along multiple dimensions, as implied by the ASD nomenclature. The 
authors postulated that the variable presentation seen in ASDs is inherent and serves as a 
hallmark of the disorders (Baird et al. 2003). Currently clinicians mainly consult two manuals in 
the diagnosis of mental disorders, the DSM-IV-TR (APA, 2000), and the ICD-10 (WHO, 1992). 
Volkmar and Klin (2005) demonstrated the similarity of the criteria levels between the two 
respective manuals concerning the ASD categories. In a field trial of the DSM-IV conducted by 
Klin, Lang, Cicchetti, and Volkmar (2000) examining the distinction between AD and non-PDD 
diagnoses, the researchers observed an excellent inter-rater reliability (k = 0.95) across all raters 
examined (i.e., experienced, inexperienced, psychologists, and psychiatrist). Due to the identified 
similarity and the popularity of use surrounding the diagnosis of ASDs in the United States, the 
present study will focus exclusively upon the DSM-IV-TR. 
The DSM-IV-TR identifies the importance of differentiation within the ASD category, to 
ensure the individual’s symptoms are not better accounted for by another ASD within the 
spectrum (APA, 2000; Ghaziuddin & Mountain-Kimchi, 2004).   Researchers have shown that 
special considerations must be used when differentially diagnosing a younger population due to 
an identified overlap of symptoms with several other early childhood disorders (e.g., general 





et al., 2003; Charman & Baird 2002; Lord, 1995; Van Daalen et al., 2009). As identified by 
Willemsen-Swinkels and Buitelaar (2002), the importance of differential diagnosis transcends 
the avoidance of misdiagnosis to include the identification of other imperatives such as 
efficacious and ethical treatments, eligibility for services, rendering of appropriate services, and 
prognosis.  The difficulty of differential diagnosis is only exacerbated by the presence of co-
occurring disorders which are frequently identified in ASDs (Baird et al., 2003; Gillberg & 
Billstedt, 2000; Matson et al., 2010; Schreck, Williams, & Smith, 2004). 
Autistic Disorder. Within the context of the five current developmental disorders of 
ASD, AD includes criteria that most closely coincide with the symptomatology originally 
documented in Kanner’s (1943) observations. A diagnosis of AD is made only if an individual is 
exhibiting “markedly abnormal or impaired development” in each of the three principal symptom 
domains as defined by the DSM-IV-TR: social interaction, communication, and a marked 
restriction in interests or activities (APA, 2000, Cheng et al., 2009; Gutierrez et al., 2009; 
Ketelaars et al., 2009; Lacroix et al., 2009; Matson & Sipes, 2010). The use of three distinct 
categories of criteria for AD remained constant in the text revisions of both the DSM-III (APA, 
1987), and DSM-IV (APA, 1994). Sevin, Knight, and Braud (2007) expressed that AD is the 
most agreed upon and consistent disorder within the ASDs category.   
Core symptoms expressed at 14 months in toddlers with AD remained relatively stable 
when re-assessed at 36 months of age (Landa, Holman, & Garrett-Mayer, 2007). In related 
research, Werner, Dawson, Munson, and Osterling (2005) reported that symptoms of AD 
observed by parents between 3-6 months became more obvious deficits in social behavior at 12–
15 months of age. When the same children were re-assessed between the ages of 3 and 4, it was 





and Horovitz (2010) suggested that identification of symptoms at earlier ages (i.e., 20 months) 
was easier when symptoms were more severe (i.e., AD versus PDD-NOS).The diagnostic clarity 
provided by the DSM-IV-TR (APA, 2000) likely contributes to the high stability observed in the 
early diagnosis of AD (i.e., 24 months). The finding of high stability rates for early diagnosis has 
been replicated across several studies (Charman et al., 2005; Cox et al. 1999; Lord 1995; Matson 
et al., 2008; Moore & Goodson 2003; Worley et al., 2011).  
 To warrant a diagnosis of AD, an individual must present with two deficits 
corresponding with impaired social interaction, at least one communication deficit, and at least 
one behavior, interest, or activity presented in a stereotypic or repetitive nature (Taheri & Perry, 
2012). Additionally, atypical or delayed functioning in at least one of three areas must be 
observed prior to 36 months of age: “(1) social interaction, (2) language as used in social 
communication, or (3) symbolic or imaginative play.” (APA, 2000, p.75; Buitelaar, Van der 
Gaag, Klin, & Volkmar, 1999). A third and final criterion requires that the presenting features 
not be more appropriately captured by either a diagnosis of Rhett’s Disorder, or Childhood 
Disintegrative Disorder (APA, 2000; Wulffaert, van Berckelaer-Onnes, & Scholte, 2009). 
Examples of the items provided for observable impairment of social interactions include but are 
not limited to: a) gross impairment of multiple nonverbal behaviors (e.g., eye contact), b) 
deficiency in emotional reciprocity, c) inability to acquire developmental or age appropriate 
relationships, and d) retarded spontaneity in the sharing of social interests (APA, 2000; Buitelaar 
et al., 1999; Hoffman, 2009; Taheri & Perry, 2012). Identified communication impairments 
include a) a delayed or total absence of a developed spoken language, b) inability to initiate or 
maintain conversations, c) the use of repetitive or stereotypic language, and d) the observed 





least one repetitive and stereotypic behavior, interest, or activity pattern must also be present, 
such symptoms include a) an abnormal focus or intense preoccupation with at least one 
stereotypic or repetitive interest pattern, b) insistence of adherence to fixed, nonfunctional rituals 
or routines, and d) a fixation with object components (APA, 2000; Buitelaar et al., 1999; Taheri 
& Perry, 2012). 
Utilizing the criterion outlined above, Fombonne (2005) estimated a prevalence rate of 
AD diagnosis at 13 per 10,000. Reviews of the criterion proposed to appear in the Diagnostic 
and Statistical Manual of Mental Disorders, 5
th
 Edition (DSM-5; proposed for publication in 
2013) has indicated a combination of the impaired social interaction domain with the 
communication deficit domain into a singular impaired social/communicative behaviors category 
(APA, 2010; Kuenssberg, McKenzie, & Jones, 2011). This combination of criteria is a source of 
controversy, as some researchers claim that such changes will greatly reduce ASD prevalence 
rates (Matson et al., 2012; Taheri & Perry, 2012). 
Pervasive Developmental Disorder – Not Otherwise Specified. In the absence of the 
specified criterion, a more sweeping parameter is provided by the DSM-IV-TR for the diagnosis 
of PDD-NOS and reads as follows: ‘‘should be used when there is a severe and pervasive 
impairment in the development of reciprocal social interaction associated with impairment in 
either verbal and nonverbal communication skills, or with the presence of stereotyped behavior, 
interests, and activities’’ (APA 2000, p.84). Additionally, a PDD-NOS diagnosis should only be 
given if the presenting symptoms are not better accounted for by other diagnoses (i.e., 
developmental disorder, schizophrenia, schizotypal personality disorder, or avoidant personality 





A PDD-NOS diagnosis is often made in light of the atypical or sub threshold presentation 
of symptoms, or the failure to meet the age of onset criterion (Buitelaar et al., 1999). The PDD-
NOS diagnosis is situated at the base of the hierarchical arrangement of ASDs as provided by the 
DSM-IV-TR (APA, 2000; Karabekiroğlu & Akbaş, 2011). Researchers have shown that 
clinicians often assign a PDD-NOS diagnosis when impairment is observed, but the child’s 
presentation fails to meet the criterion for another diagnosis on the spectrum (APA, 2000; 
Buitelaar et al., 1999; Lord & Risi, 1998; Matson & Boisjoli, 2007; Tidmarsh & Volkmar, 2003).  
The PDD-NOS category and especially early diagnosis is a point of much contention. 
Towbin (2005) mentioned specific concern surrounding the ambiguity of the current criteria and 
current diagnostic utilization of PDD-NOS. A recent meta-analysis investigating the stability of a 
PDD-NOS diagnosis utilizing the DSM-IV-TR criterion further highlighted researchers’ 
concerns. Rondeau and colleagues (2011) investigated the findings of eight longitudinal studies, 
which included a diagnosis made prior to 36 months of age and found that only 35% of those 
individuals initially diagnosed retained the PDD-NOS diagnosis at a subsequent 3-year follow-
up. Stone and colleagues (1999) followed 65 children who received an initial AD or PDD-NOS 
diagnosis at age 2. When the same children were subsequently re-evaluated at age 3, a greater 
diagnostic instability (i.e., no diagnosis, or change to AD diagnosis) was observed in those with 
PDD-NOS than in children who were diagnosed with AD (Stone et al., 1999). Similarly, Worley, 
Matson, Mahan, Kozlowski, and Neal (2011) examined the stability of early diagnosis in 114 
toddlers and reported that 15.8% of toddler’s diagnoses changed from either PDD-NOS to 
atypical development or vice versa.  
The indistinct nature of the criteria provided for PDD-NOS has been suggested as a 





(Buitelaar et al., 1999; Chawarska, Klin, Paul, & Volkmar, 2007; Nebel-Schwalm & Matson, 
2008; Tidmarsh & Volkmar, 2003). Stone and colleagues (1999) suggested that the greater 
stability observed in AD when compared to PDD-NOS may be reflective of “a more coherent or 
well-defined symptom cluster” (p. 224). The authors further suggested that the stability of AD is 
bolstered by the severity of symptoms required for diagnosis (Stone et al., 1999). In addition to 
relatively vague criteria, other concerns have been voiced. Siegel (1991) expressed the concern 
that depending on the age at which they are assessed, some deficits may not yet be clearly 
evident or applicable (e.g., the children may not have peer friends, or the opportunity to develop 
atypical speech patterns). 
In a recent study of PDD-NOS using DSM-IV-TR criteria, Fombonne (2005) identified an 
incidence rate of 20.8 per 10,000.  Consequently, the incidence for PDD-NOS is higher than 
either AD or AS. Despite the observed increase in prevalence rate, PDD-NOS is identified as 
being studied significantly less than any other ASD (Chakrabarti & Fombonne, 2005; Matson & 
Boisjoli, 2007). Recent reviews of the proposed changes in DSM-5 have reported that the 
changes in criteria will increase diagnostic sensitivity and specificity. Huerta, Bishop, Duncan, 
Hus, and Lord, (2012) reported that the DSM-5 is working to create a single diagnostic category 
of autism spectrum disorder (ASD). Under the proposed changes, the current three-domain 
model will be replaced by a two-domain model, the age of onset criteria will be relaxed, and 
additional criteria will include symptoms not previously included in DSM-IV-TR (e.g., sensory 





COMORBID PSYCHOPATHOLOGY IN ASD 
De Graaf, Bijl, Smith, Vollebergy, and Spijker, (2002) described the comorbidity of 
psychiatric disorders as “the presence, simultaneously or in sequence, of two or more disorders 
in a person within a certain period of time.” Researchers are in agreement that “pure” disorders 
are relatively infrequent and that most cases involve a client meeting criteria for two or more 
disorders simultaneously (Goldstein, Lopez, & Puente, 2011). Within the context of the current 
paper, the term “comorbid” refers to the presence of an ASD and one or more concurrent 
psychiatric disorders. 
Since the initial documentation of children with an ASD, behaviors other than the core 
symptoms were observed, such as inattentiveness, food selectivity, tantrums, and abnormal 
attention to detail (Brereton, Tonge, & Einfeld, 2006; Kanner, 1943; LoVullo & Matson, 2012). 
In comparison to research investigating comorbid psychopathology in other disorders, Matson 
and Nebel-Schwalm (2007) suggested that the same research in the ASD population is relatively 
absent. In addition to a general deficit of researchers investigating comorbid psychopathology in 
the ASD population, Angold and Egger (2004) reported that such studies are extremely rare in 
young children.  Researchers have expressed that the variation in presentation of some disorders 
may be more easily identified as distinct from an ASD (e.g., depression), while others are in-line 
with ASD symptomology (e.g., obsessive-compulsive disorder; Matson & Nebel-Schwalm, 
2007). Given this information, Matson and Nebel-Schwalm (2007) suggested a cautionary 
approach to the diagnosis of comorbid psychopathology. 
Current Conceptualization  
Until recently researchers expressed disagreement concerning the presence of comorbid 





Child and Adolescent Psychiatry (1999) suggested that the presence of emotional problems and 
challenging behaviors within the ASD population may not warrant additional diagnosis, instead 
being better expressed as symptom clusters related to ASD. Hess, Matson, and Dixon (2010) 
indicated that much of the disagreement surrounding comorbid diagnosis has stemmed from a 
dearth of assessments available for the identification of comorbid disorders. While measures of 
comorbid psychopathology are relatively common for the general population, few are normed for 
an ASD population (Matson et al., 2010). The variation of both severity and functional abilities 
within the ASD population impacts the presentation of psychiatric symptoms, thus increasing the 
difficulty of accurate assessment and subsequent differential diagnosis (Gillberg & Billstedt, 
2000; Matson & Rivet, 2008; Tsai, 1996).  
Researchers targeting children with ASDs have consistently replicated results showing 
higher occurrence rates of comorbid disorders when compared to their typically developing peers 
(Gillberg & Billstedt, 2000; Kim, Szatmari, Bryson, Streiner, & Wilson, 2000; Schreck et al., 
2004). For ASD, estimates of the psychiatric comorbidity rate have ranged from 35% (Morgan, 
Roy, & Chance, 2003) to 70% (Simonoff et al., 2008). A review of current literature reveals 
multiple studies highlighting the symptomology overlap between ASDs and comorbid disorders 
(Attention-Deficit/Hyperactivity Disorder; ADHD), as well as psychiatric symptoms such as 
depression or anxiety (Ghaziuddin, Ghaziuddin, & Greden,, 2002; Hallett, Ronald, & Happe, 
2009; Simonoff et al., 2008).  Despite the growing interest in comorbid psychopathology in 
ASD, much of the research is limited to older children, adolescents, and adults. Matson and 
colleagues (2010) recognized the sparse knowledge of comorbid psychopathology symptoms 






The observed high prevalence rate of comorbid symptoms has been suggested to be 
further influenced by the presence of another disorder found to commonly co-occur with ASD, 
intellectual disability (Matson & Shoemaker, 2009). Researchers have shown that 50-75% of the 
ASD population also meet criteria for a concurrent diagnosis of intellectual disability (Matson & 
Shoemaker, 2009; Rutter & Schopler, 1987; Wing, 1981; Wing & Gould 1979). The overlap 
between ASD and intellectual disability is critical as both populations are associated with 
increased risk for comorbid disorders (Borthwick-Duffy & Eyman, 1990; Bregman, 1991; 
LoVullo & Matson, 2009; Matson & Shoemaker, 2009). Trillingsgaard, Sørensen, Nemec, and 
Jørgensen (2005) identified that the difficulty of early ASD diagnosis is compounded by the high 
co-occurrence of intellectual disability and the symptomology overlap with other developmental 
disorders (e.g., impaired communication and social interaction). Attempts to identify additional 
markers that may aid in the differentiation of developmental disorders have not been fruitful. 
Researchers attempting to identify factors such as age, sex, or intelligence quotient as significant 
predisposing factors for developing a comorbid disorder in children with ASD have been 
unsuccessful (Brereton et al., 2006; Worley & Matson, 2011). 
The development of interventions for ASD has advanced despite the remaining difficulty 
of diagnostic differentiation. While no identified treatment is unanimously considered the most 
effective intervention for ASDs, there has been a steady increase in the popularity and perceived 
benefit of early intervention for ASDs (Hwang, Hughes, 2002; Rogers, 1996; Tanguay, 2000). A 
growing body of research has linked the early identification and diagnosis of ASDs and 
comorbid psychopathologies with increased rates of success surrounding the implementation of 
early intensive intervention programs (Ben-Itzchak, Lahat, Burgin, & Zachor, 2008; Eaves & 





early intensive behavioral intervention (EIBI) for the improvement of various functioning 
domains within toddlers with ASD has been suggested (Granpeesheh, Tarbox, & Dixon, 2009; 
Reichow, 2012; Worley et al., 2011).  
EIBI has been touted as critical for the improvement of an individuals’ long-term 
prognosis following replication in multiple studies (Lord, 1995; Matson & Smith, 2008; Mays & 
Gillon, 1993; Prizant & Wetherby, 1988; Reichow, 2012). In an initial study investigating the 
impact of EIBI, Lovaas (1987) reported a success rate of 47% for those children who received 
EIBI (i.e., intelligence quotient >85 and unassisted placement in a general education setting). 
Since Lovaas’s (1987) exploratory study, a growing body of research supporting EIBI’s efficacy 
has accumulated. In a review of five separate meta-analyses investigating the efficacy of EIBI, 
Reichow (2012) found that on average, the effects produced were strong and robust. However, 
the research also highlighted the fact that no treatment to date has been effective for every child 
with ASD (Reichow, 2012). The variance seen in treatment effectiveness can no doubt be 
attributed to a multitude of factors. Wallace and Rogers (2010) identified the individualization of 
treatment as a key factor in the development of effective interventions. Additionally, the 
presence of comorbid psychopathological conditions has been identified as a significant factor 
that would necessitate an individualized treatment regimen (Bakken et al., 2010; Gillberg, 2010; 
LoVullo & Matson, 2009).   
Despite such emphasis and interest in early intervention, there has been little research 
attempting to advance our understanding of ASDs and comorbid psychopathology symptom 
manifestation in infants (DeGiacomo & Fombonne, 1998; Howlin & Moore, 1997; Matson et al., 
2010; Siperstein & Volkmar, 2004). The importance of the early and accurate identification of 





successful ventures (Hess, Matson, & Dixon, 2010). The necessity of accurate diagnosis 
becomes especially important when comorbid disorders are present, as this often creates a need 
for highly specialized intervention centered upon the individual’s unique presentation (Joshi et 
al., 2010). Researchers have highlighted the necessity of identifying psychopathologies in 
children with ASDs based upon the perceived benefits of the multiple treatment options available 
to include: educational, pharmacological, social interventions, and psychological treatments 
(Birmaher, Quintana, & Greenville, 1988; Ghaziuddin, 2002; Howlin, 1998).  
Common Comorbid Symptoms in ASD 
Researchers examining comorbid psychopathology in children with ASD have shown 
increased occurrence rates of both internal and external symptoms associated with multiple 
psychopathological disorders (e.g., ADHD, anxiety disorder, conduct disorder; Hallett, Ronald, 
& Happe, 2009; Hayashida, Anderson, Paparella, Freeman, & Forness, 2010;  Simonoff et al., 
2008; Skuse et al., 2009).  The increased occurrence of anxiety symptoms in ASD populations in 
comparison to both typically and atypically developing populations is well founded (Farrugia & 
Hudson, 2006; Kim, Szatmari, Bryson, Streiner, & Wilson, 2000; Russell & Sofronoff, 2005). 
Evans, Canavera, Kleinpetere, Maccubbin, and Taga (2005) determined that children with ASDs 
exhibit significantly higher levels of fears and phobias than those with Down syndrome (DS), 
mental age peers, and chronological peers. The researchers also identified a positive correlation 
between the presence of fears and phobias and increased hyperactivity, impulsivity, and conduct 
behaviors in children with ASD (Evans, Canavera, Kleinpetere, Maccubbin, & Taga, 2005). 
Muris, Steerneman, Merckelbach, Holdrinet, and Meesters (1998) expressed the importance of 
identifying and treating anxiety symptoms due to the impairment of daily functioning and 
distress these symptoms cause. While researching anxiety symptoms in children with ASD, 





functioning impairment, and the severity of symptoms commonly associated with social anxiety 
disorder. Matson, Mahan, Sipes, and Kozlowski (2010) suggested that the extreme variation in 
comorbid symptoms can be generally combined into five major categories: tantrum/conduct 
behavior, inattention/impulsivity, anxiety/repetitive behavior, avoidance behavior, and 
eating/sleeping problems.   
Tantrum/Conduct Behavior. The comorbid incidence of tantrum and conduct behaviors 
within the ASD population is acknowledged as a contributing factor associated with a poor 
prognosis due to its hindrance of intervention strategies (Matson et al., 2010). Researchers 
comparing rates of conduct behavior in typically developing individuals and those with an ASD 
have identified significantly higher rates of aggression and tantrum behaviors within the ASD 
population (Horner, Carr, Strain, Todd, & Reed, 2002). Dominick, Davis, Lainhart, Tager-
Flusberg, and Folstein (2006) reported that 70% of the children with autism included in their 
study had experienced severe tantrums. Additionally, the authors reported that onset of tantrums 
occurred before 3 years of age in half of the participants. Elsewhere, researchers have found 
tantrum behaviors to occur more frequently in children with ASD than their peers diagnosed with 
intellectual disability (Ando & Yoshimura, 1979). Utilizing the BISCUIT-Part 3 Matson and 
colleagues (2010) observed an increase in the endorsement for all challenging behaviors (e.g., 
Aggressive and Destructive Behavior, Stereotypies, and SIB) when symptoms of comorbid 
psychopathology were also present. Robb (2010) suggested that symptoms linked to irritability 
such as temper tantrums and aggression are major predisposing factors leading to problems in 
multiple environments (e.g., school, home), and that these behaviors often result in referrals for 





Conduct disorder and challenging behaviors have been identified as behavior which 
violates societal norms or the basic rights of others, or are a grave violation of established rules 
such as aggression, property destruction, and theft (APA, 2000; Essau & Anastassiou-
Hadjicharalambous, 2011; Lahey & Waldman, 2012; Singh, Lancioni, Winton, & Singh, 2011). 
Tantrums are often identified as challenging behaviors that encompass a wide-ranging 
continuum of severity and form. Daniels, Mandleco, and Luthy (2012) defined temper tantrums 
as extreme and episodic frustration or anger. Tantrum behaviors often include screaming, crying, 
hitting, and throwing items (Davidson, 2006; Potegal & Davidson, 2003). Matson and Neal 
(2009) identified aggression, non-adherence, property destruction, and self-injury as challenging 
behaviors commonly observed in individuals with ASD. These behaviors often become a clear 
deviation from the norm when the child first enters a scholastic setting (Pringle, Colpe, 
Blumberg, Avila, & Kogan, 2012). This context allows for the direct comparison to peers, 
highlighting the differentiation and is often the reasoning for treatment referrals, and subsequent 
screening (Wiggins, Baio, & Rice, 2006). Prior to any diagnosis, it is important to differentiate 
the hypothesized cause surrounding the presentation of tantrum and conduct behaviors (Didden 
et al., 2012). For example, behaviors such as head banging could be elicited due to the 
experienced discomfort stemming from an undiagnosed medical condition, instead of an ASD. 
Similarly, in a study examining the presentation of conduct behavior, Evans and colleagues 
(2005) found a strong positive correlation between the presence of fears and phobias and conduct 
behaviors.  
Inattention/Impulsivity. Several studies have revealed that in comparison to their 
typically developing peers, children diagnosed with ASDs exhibit symptoms associated with 





Kim et al., 2000; Lee & Ousley 2006; Leyfer et al., 2006; Simonoff et al., 2008). Lee and Ousley 
(2006) identified significantly higher hyperactivity-impulsivity scores in children and 
adolescents with autism than their peers regardless of ASD type. The presence of ADHD is 
commonly associated with impaired social and communication skills, both of which are 
symptoms commonly seen in children with ASDs (Holden & Gitlesen, 2006; Matson & Wilkins, 
2008; McConaughy, Volpe, Antshel, Gordon, & Eiraldi, 2011; Schreck &Williams, 2006; Selfe, 
2002; Sibley, Evans, & Serpell, 2010). Despite supportive research, a comorbid diagnosis of 
ADHD when an ASD is present is currently prohibited by the DSM-IV-TR (APA, 2000; Willcutt 
et al., 2012).  Regardless, intervention remains crucial due to the observed impairment of 
individuals interactions in multiple settings (e.g., home and school) associated with symptoms of 
hyperactivity and impulsivity (Loveland & Tunali-Kotoski, 2005).  
Willcutt and colleagues (2012) identified three different diagnoses associated with 
inattention and impulsivity; ADHD, predominantly inattentive type, ADHD, predominantly 
hyperactive-impulsive type, and ADHD, combined type. In order to meet criteria for any of the 
above ADHD types, a child must present with symptoms that are considered to be maladaptive 
and different from their peers for a period of at least six months (Willcutt et al., 2012). This 
qualifier is also accompanied by an age criterion indicating that some impairment be present 
prior to the child’s seventh birthday (APA, 2000; Sibley et al., 2012, Willcutt et al., 2012). 
Additional criteria requires that the behaviors occur in more than one setting (e.g., at home and at 
school), cause clinically significant impairment in social, academic, or occupational functioning, 
and they must not occur in-conjunction with a psychotic disorder (e.g., Schizophrenia), or be 
better accounted for by another mental disorder (e.g., mood disorder, anxiety disorder; APA, 





Avoidance Behavior. The active avoidance of social situations, events, or places, is a 
broad description of the behavior commonly observed within the ASD population. Schleismann 
and Gillis (2011) identified that avoidance behaviors in children with ASD can be both physical 
(e.g., hiding, running away) and verbal (e.g., negative verbalizations). Escape behaviors such as 
the examples given above impede both intervention and caregiving. Similarly, escape maintained 
behaviors driven by the social aversion commonly witnessed in the ASD population negatively 
impact the areas of education, and employment (Kemp & Carr 1995; Moore, Yufang, McGrath, 
& Powell, 2005; Reese, Richman, Belmont, & Morse, 2005). 
 Multiple factors have been identified as influencing avoidant behaviors. One 
comparative analysis suggested that disruptive/avoidant behaviors by individuals with an ASD 
are maintained by factors of both attention and escape (Reese, Richman, Belmont, & Morse, 
2005). When discussing their results, the authors postulated that gender may operate as an 
influencing factor upon behavior function (Reese et al., 2005). Matson and Hess (2010) found 
that when compared to a PDD-NOS and a control group, children with AD evinced significantly 
greater avoidance behaviors. The increased prevalence of avoidant behaviors in children with 
ASD is compounded by an observed increase in the severity of these behaviors. Utilizing the 
BISCUIT-Part 2 to assess the severity of avoidance behavior in a sample of 309 infants and 
toddlers with an ASD diagnosis, Matson, Boisjoli, and Wilkins (2007) found 8.7% exhibiting 
moderate impairment and 6.1% exhibiting severe impairment. The presence of avoidance 
behaviors has also been linked to the presence of other comorbid symptoms.  Schleismann and 
Gillis (2011) found an increase in avoidance behaviors when both ASD and symptoms of an 
anxiety disorder were present. Other researchers have found that when compared to both 





increased rates of fears and phobias. These researchers postulated that the elevated experience of 
fear and phobias may be directly related to the presentation of avoidance behaviors (Evans, 
Canavera, Kleinpeter, Maccubbin, & Taga, 2005; Matson & Love, 1990).  
Anxiety/Repetitive Behavior. The presence of restricted and repetitive behaviors has 
been consistently recognized across the development and evolution of the ASD category. Kanner 
(1943) described the behaviors he observed as repetitious, high in frequency, and seemingly 
oriented towards preservation of environment. Despite being a core symptom in ASDs, Lewis 
and Bodfish (1998) acknowledged the relative lack of research being conducted on restricted and 
repetitive behaviors. Bodfish, Symons, Parker, and Lewis (2000) hypothesized that the relative 
ambiguity of terminology being utilized as descriptors for restricted and repetitive behaviors has 
acted as a source of hindrance upon further development and advancement within the area. The 
present categorization of restricted and repetitive behaviors provided by the DSM-IV-TR has 
been identified as being a source of further hindrance upon the research due to the broad range of 
behaviors it encompasses. To address this broad range of behaviors, multiple researchers have 
proposed a mixed categorization approach (Bodfish et al., 2000; Cuccaro et al., 2003; 
Papageorgiou, Georgiades, & Mayreas, 2008; Szatmari et al., 2006). Such a mixed categorization 
has been suggested to be implemented in a mock hierarchical fashion in an effort to distinguish 
between what researchers identified as “high order” behaviors (i.e., compulsive/impulsive 
behaviors) and “low-order” behaviors (e.g., repetitive speech, and sensory/motor behaviors; 
Cuccaro et al,.2003; Szatmari et al., 2006).  
Hand flapping, body rocking, and the repetitive use of words or phrases are examples of 
observed stereotypies in children with ASDs (O’Reilly et al., 2010). These challenging behaviors 





individual’s social encounters (Lam & Aman, 2007), familial life (Gordon, 2000), and education 
(Sigafoos, Arthur, & O’Reilly, 2003;  Varni, Lovaas, Koegel, & Everett, 1979).When compared 
to other atypically developing populations, there is an significant increase in the prevalence of 
stereotypic restricted and repetitive behaviors within the ASD population (Green et al., 2006; 
Lord & Pickles, 1996; Szatmari, Bartolucci, & Bremner, 1989; Turner, 1999). Researchers have 
expressed the importance of investigating symptoms of restricted and repetitive behaviors due to 
the negative impact they have upon a child’s prognosis due to their inherent complication of their 
behavioral repertoire and social stigmatization (Howlin, 1998; Howlin & Moss, 2012).  
The presence of anxious behavior has been observed continuously since the original 
discovery of ASD. Kanner (1943) described it as “anxiously obsessive desire for the 
maintenance of sameness.” (p.245). Of the ten different anxiety disorders recognized by the 
DSM-IV-TR (APA, 2000), researchers highlight the common occurrence of symptoms associated 
with panic disorders, obsessive-compulsive disorder, and social anxiety disorder within the ASD 
population (Tantum, 2000). Research by Gillott, Furniss, and Walter (2001), highlighted specific 
endorsement increases on the subscales of symptoms associated with separation anxiety and 
obsessive-compulsive disorder when an ASD was present. The presence of anxiety symptoms 
has also been linked to the individual’s level of intellectual functioning. Adults with high 
functioning autism have been identified as exhibiting rates of co-morbid obsessive-compulsive 
disorder as high as 25% based upon ICD-10 criteria (Russell, Mataix-Cols, Anson, & Murphy, 
2005). The influence of these comorbid symptoms transcends their immediate impact and has 
been shown to influence other behaviors. For example, the presence of repetitive behaviors and 
anxiety has been shown to have a strong correlation with increased levels of aggressive and 





Eating Problems. Among the eating disorders defined by the DSM-IV-TR, the current 
study will focus only upon symptoms associated with three due to their elevated co-occurrence in 
ASDs.  Symptoms of Pica, rumination, and feeding disorder of infancy or early childhood have 
all been observed at increased rates in individuals with ASD (Matson, Hattier, & Turygin, 2012; 
Råstam, 2008). A diagnosis of pica is centered upon the appetite for and purposeful ingestion of 
non-nutritive substances (Matson et al., 2012; Tewari et al., 1995). Due to the potential 
influences of cultural beliefs, chemical imbalances, and social skills, researchers caution that a 
formal diagnosis should only be ascribed after the investigation of extraneous influences (Matson 
et al., 2012; Seiverling, Williams, & Sturmey, 2010). Rumination involves the regurgitation of 
food after a meal with the intent of re-experiencing the previously eaten items. Involuntary 
occurrences due to gastrointestinal illness or a presenting medical condition must be ruled out 
before an individual may be diagnosed with rumination (Darling, Otto, & Buckner, 2011; Lang 
et al., 2011; Råstam, 2008). The diagnosis of a feeding disorder during infancy or early 
childhood occurs specifically before six years of age and involves the failure to consume enough 
food across no less than one month to allow for normal growth and weight gain (Chatoor, 2002; 
Bruns & Thompson, 2010). In addition to symptoms associated with the above disorders, 
children with ASDs often exhibit behaviors that inhibit or complicate meal consumption. 
However, these behaviors are not diagnosable disorders, such as food selectivity (e.g., 
temperature, texture, liquid avoidance, and color), or food refusal (Seiverling, Williams, & 
Sturmey, 2010). 
Across time, a trend of increasing eating and sleeping complications has been 
documented within the ASD population (Kanner, 1943; Richdale, 1999; Shreck et al., 2004). 





correlation between a group of children diagnosed with an ASD and early onset eating disorder 
when compared to their typically developing peers. However, the researchers observed that those 
with an early onset eating disorder consistently expressed elevated levels of ASD traits. Williams 
and Seiverling (2010) showed that of the available data and reports on feeding problems, food 
selectivity was the most prevalent in children with ASDs. An examination of feeding program 
referrals, found that 46% of children with an ASD diagnosis presented with symptoms of food 
selectivity (Bowers, 2002). While researchers have investigated the presence of eating disorders 
in children and adults, there is only minimal research investigating occurrence in an infantile 
ASD population. While commenting on the paucity of research of eating disorders in infants 
with ASDs, Pooni and colleagues (2012) urged the use of caution in attempting to supplement 
the knowledge gap with generalized research from an adult population. 
Sleeping Problems. Another comorbid disturbance afflicting the ASD population 
involves sleep. Currently researchers suggest that younger children with ASD most often 
experience symptoms associated with bedtime resistance, sleep anxiety, parasomnias, and night 
waking’s (Goldman, 2012; Park et al., 2012; Xianchen et al., 2006). In direct agreement with this 
finding, researchers analyzing parental reports have shown that the rates of reported sleep 
problems in individuals with an ASD (50%-80%) is significantly more prevalent then 
comparison group rates (9% to 50%; Allik, Larsson, & Smedje, 2006; Couturier, et al., 2005; 
Malow et al., 2006; Polimeni, Richdale, & Fancis, 2005; Xianchen et al., 2006). Richdale (2001) 
suggested that two-thirds of children in the ASD population will experience a sleep problem. 
Gillberg and Coleman (1992) proposed the autistic population is one in which etiology 
varies tremendously based upon a multitude of factors (e.g., genetic, metabolic, and 





disturbances.  The presence of a sleep problem has been shown to correlate with the presence of 
other comorbid psychopathology symptoms, such as: internalizing and externalizing problems, 
aggression, somatization problems, and withdrawal (Park et al., 2012; Xianchen et al., 2006). 
Additionaly, Park and colleagues (2012) identified the significant influence of child-rearing on 
sleep behaviors. The authors exemplified the factorial influence by identifying an elevated risk of 
major depression when symptoms of depression (e.g., sleep and appetite disturbance) are 
combined with the presences of histrionic familial affective disorders. Sleep disturbances have 
been demonstrated to not only affect the child themselves negatively, but researchers have 
suggested that the influence also impacts parental quality of life (Lam, Hiscock, & Wake, 2003; 





COMORBID PSYCHOPATHOLOGY IN NON-ASD 
ASDs aside, other developmental disorders are included within the DSM-IV-TR, a 
number of which are also positively correlated with increased rates of comorbid 
psychopathology. When compared to their typically developing peers, children with atypical 
development without an ASD also encounter increased rates of comorbid psychopathology 
(Matson, Fodstad, Mahan, & Sevin, 2009; Tervo, 2007) and challenging behaviors (Baker, 
Blacher, Crnic, & Edelbrock, 2002; Dixon, Kurtz, & Chin, 2008; Matson, Neal, Fodstad, & 
Hess, 2010; Murphy et al., 2005).  
Egger and Angold (2006) identified five groups of psychiatric disorders that are 
commonly found in atypically developing children: ADHD, oppositional defiant and conduct 
disorders, anxiety disorders, and depressive disorders. Deficiencies in communication and motor 
skills have similarly been identified (Matson, Mahan, Kozlowski, & Shoemaker, 2010). Of great 
importance is the fact that these impairments are not isolated incidents linked to a singular 
disability and have been identified in children with a variety of developmental diagnoses such as; 
intellectual disability, premature birth, epilepsy, Down Syndrome, and seizure disorder (APA, 
2002; Coe et al., 1999; Perry, Flanagan, Geier, & Freeman, 2009; Ghaziuddin, Tsai, & 
Ghaziuddin, 1992; Matson et al., 2010; Oliver & Buckley, 1994; Stephenson & Dowrick, 2005). 
Matson, Mahan, Kozlowski, and Shoemaker (2010) found that in general, when the ASD 
population was compared with other diagnoses within the atypically developing population, the 
latter generally reached each developmental milestone earlier than individuals with an ASD. 
While the occurrence of comorbid psychopathology and challenging behaviors is exhibited by 
the atypically developing population, recently researchers have shown that the frequency is 





al., 2010). However, in order for proper intervention and services to be rendered, the early 
identification and proper diagnosis remains paramount regardless of diagnosis or prevalence rate.  
Common Comorbid Symptoms in non-ASD 
Researchers investigating the atypically developing population indicate that the 
individual’s primary diagnosis may serve as a predisposing factor for the development of 
concomitant psychopathology. For instance, when compared to peers without Cerebral Palsy, 
children with Cerebral Palsy were found to exhibit increased rates of symptoms associated with 
hyperactivity, conduct, and emotional problems (Parkes & McCusker, 2008). Comorbid 
symptoms such as ADHD, or conduct problems have been frequently observed in those 
diagnosed with Down syndrome (Myers & Pueschel, 1991; Roizen & Patterson, 2003). Within 
the intellectually disabled population, researchers have commonly observed symptoms of 
depression, anxiety disorders, and ADHD (Deb, Thomas, & Bright, 2001; Dekker & Koot, 2003; 
Hastings, Beck, Daley, & Hill 2005). Of those diagnosed with a Tic Disorder studies have shown 
that between 35-50% exhibit symptoms sufficient to meet diagnostic criterion for ADHD 
(Freeman, 2007; Kurlan et al., 2002; Wang & Kuo, 2003). Further, Dimitropoulos, Blackwell, 
Walden, and Thompson (2006) observed a significant increase in the frequency of ritualistic 
behaviors in children with Prader-Willi syndrome (PWS) then in children with a developmental 
delay, but failed to find a significant difference in severity.  
The prevalence of concomitant psychopathology within the intellectually disabled 
population has been estimated to occur within 4-40% of the population (Deb et al., 2001; Dekker 
& Koot, 2003; Rojahn, Borthwick-Duffy, & Jacobson, 1993). An increase in challenging 
behaviors (e.g., aggressive and destructive behaviors) was positively correlated with the presence 





(Matson et al., 2010). Despite the surge of research surrounding the ASD population, it is 
important to note that the largest group of atypically developing infants and toddlers are those 






  A dearth in identified organic markers has led to an increased reliance upon observations 
and the use of diagnostic measures for diagnosing ASDs (Baird et al., 2003; Matson & Neal, 
2009). As knowledge of ASDs has increased, so has the availability of assessment measures and 
screeners to identify autistic symptoms. The Modified Checklist for Autism in Toddlers (M-
CHAT) is a 23-item parent report checklist with answers being provided in a “yes/no” format 
(Robins, Fein, Barton, & Green, 2001). It was developed specifically to screen toddlers (16-30 
months) for the presence of ASDs (Robins et al., 2001). The Battelle Developmental Inventory, 
Second Edition (BDI-2) is a comprehensive assessment battery of functional abilities across five 
developmental domains: (a) personal-social, (b) adaptive, (c) motor, (d) communication, and (e) 
cognitive (Alfonso, Rentz, & Suehee, 2010). The BDI-2 is often used to identify current 
developmental level, assess for children “at-risk” for developmental delays, and identify 
strengths and weaknesses of typically and atypically developing children (Newborg, 2005). The 
screening portion of the BDI-2 requires 10 to 30 minutes for administration (Newborg, 2005). 
Additional diagnostic measures for ASDs include but are not limited to the Autism 
Diagnostic Interview-Revised (ADI-R; Lord, Rutter, & Le Couteur, 1994), Baby and Infant 
Screen for Children with aUtIsm Traits (BISCUIT; Matson et al., 2007) the Childhood Autism 
Rating Scale (CARS; Schopler, Reichler, & Renner, 1986). As discussed previously, multiple 
behaviors have been identified as commonly occurring in toddlers with ASDs (Baranek, 1999; 
Matson & Wilkins, 2008; Osterling & Dawson, 1994; Teitelbaum, Teitelbaum, Nye, Fryman, & 
Maurer, 1998). Therefore clinicians often utilize direct observation measures to complement 





Diagnostic Observation Schedule-Generic (ADOS-G) is an example of a standardized 
observation measure (Lord et al., 2000).  
However, researchers have noted the inability to utilize observation measures when 
evaluating older children and when direct observation is not an option (Charman et al., 2003; 
Matson & Wilkins, 2008). Different groups of researchers have examined home videos of ASD 
children and compared them to videos of typically developing peers to identify behaviors unique 
to ASD (Matson & Wilkins, 2008). The inability to standardize home video observation is an 
identified flaw in such an approach, but it remains a valuable resource in the evaluation of older 
children (Charman et al., 2003; Matson & Wilkins, 2008). The observation of poor visual 
orientation and attention, object mouthing, unusual body posture, and aversion to social touch 
were suggested by multiple researchers as unique in toddlers with ASD (Baranek, 1999; 
Osterling & Dawson, 1994; Teitelbaum, Teitelbaum, Nye, Fryman, & Maurer, 1998). 
Researchers also noted the common occurrence of certain “autistic behaviors” (e.g., covering 
ears, stereotypies), social behavior, and joint attention as additional differences in toddlers with 
ASD during home video analysis (Matson & Wilkins, 2008).   
Assessment of Comorbid Psychopathology 
The expansion of researchers investigating ASD and comorbid psychopathologies has led 
to an increase in knowledge of the symptoms and features of ASDs. Tsai (2000) acknowledged 
the existence of psychiatric symptoms as separate from ASD symptomology, a matter which was 
previously the source of much debate. Howlin and Moss (2012) also demonstrated that if 
symptoms of comorbid psychopathology are left untreated they continue to plague those with 
ASD even as they mature into adulthood. Matson and Nebel-Schwalm (2007) suggested that 





population should assess for them multiple times due to the often cyclical presentation associated 
with psychiatric disorders. This distinction made necessary the development of assessments to 
properly detect the presence of concomitant psychopathologies in children. As agreement 
concerning the presence of comorbid symptoms and the benefit of early intervention (e.g., EIBI) 
has increased, researchers have explored the validity of assessing comorbidity in an infantile 
populace (Dawson, 2008; Lovaas, Schreibman, & Koegel, 1974; Remington, et al., 2007; Smith, 
Groen, & Wynn, 2004). However, until recently, an acknowledged gap in the research of 
infantile ASD has been the lack of assessment measures analyzing psychopathology with ASD 
norms (Matson et al., 2010).  
The results gathered from early assessment of comorbid psychopathology help to identify 
problems unique to an individual child which would allow for the customization of an 
intervention strategy. Further, the compilation of research mapping the presence of comorbid 
psychopathology in an infantile ASD population would aid in advancing understanding of the 
presenting features and symptoms commonly observed in ASDs. The early recognition of 
comorbid psychopathology may also aid in the identification of patterns or characteristics which 
may help educate the individual’s family and caretakers by drawing their attention to the 
complex nature of the disorders’ interactions they are being confronted with and affording them 
the opportunity to educate themselves (Williams & Brayne, 2006). Increased knowledge would 
also allow parents to explore other services available to them such as genetic counseling which 
would include recurrence rates and inform reproductive decisions (McMahon, Baty, & Botkin, 
2006; Simonoff, 1998).  
Worley and Matson (2011) stressed the importance of caution and thorough assessment 





ASD diagnosis. Assessment and interpretation is complicated due to the large variation in range 
of functional abilities inherent to the hierarchical orientation of the ASD category. These factors 
combined with the necessity of accurate diagnosis for efficacious intervention, make accurate 
differential diagnosis crucial (Gillberg & Billstedt, 2000; Tsai, 1996).  
Researchers have suggested that the manifestation and expression of comorbid 
psychopathological symptoms within ASDs are unique and different from the presentation seen 
in other disorders (Matson et al., 2007). While assessment measures such as the Behavioral 
Assessment System for Children-Second Edition (BASC-2) and Child Behavior Checklist for ages 
1.5-5 (CBCL) screen for the presence of comorbid psychopathology, these measures do not 
include the norms necessary to account for the unique presentation witnessed in an ASD 
population.  The development of the BISCUIT-Part 2 has filled this gap (Matson, Wilkins, 
Knight, Boisjoli, & Sharp, 2009).     
Behavioral Assessment System for Children-Second Edition  
The BASC-2 assessment battery is designed to assess psychopathology in toddlers as 
young as 24 months of age and spanning up to adults 25 years of age (Reynolds & Kamphaus, 
1992). The assessment battery contains a comprehensive set of forms whose inclusion is 
dependent upon the assessed person’s age such as Teacher rating scale (TRS), Student 
observation system (SOS), and a parent rating scale (PRS). With an average administration time 
of 20 minutes, the Preschool TRS consists of 100 items. Item responses are rated based upon a 
four-point scale reflecting the frequency of occurrence: N (never), S (sometimes), O (often), and 
A (almost always; Reynolds & Kamphaus, 2004). The Preschool PRS utilizes a similar four-
point response scale for the 134 items presented. Both scales assess for the presence of 





anxiety, depression, and inattention (Reynolds & Kamphaus, 2004). This measure is limited by a 
major factor relative to the interests of the present study; its normative age range, which begins 
at two years of age, which would prevent it from being useful in early identification and 
intervention approaches (Reynolds & Kamphaus, 2004).  
Researchers are consistently placing emphasis on the early identification and intervention 
in toddlers with ASD. The American Academy of Pediatrics (AAP) has placed an emphasis on 
early identification by encouraging pediatricians to carry out ASD screeners at a child’s 18 and 
24 month well-child checkups. Further supporting the role of early assessment, Matson and 
Smith (2007) suggested participation in intervention programs for children diagnosed with an 
ASD as early as 18 to 24 months of age. The unique symptoms observed in the ASD population 
has led researchers to acknowledge the need for a measure that is designed to aid in the 
identification and classification of symptoms that are indicative of either a concomitant 
psychopathology, or being better described by the presence of an ASD (Matson, Boisjoli, & 
Wilkins, 2007). 
Child Behavior Checklist for ages 1.5-5 
 The need for the early assessment of psychopathology (i.e., 18 months of age) was 
addressed by the development of a parent-report measure known as the CBCL (Achenbach & 
Rescorla, 2000). The CBCL is a part of the Achenbach System of Empirically Based Assessment 
(ASEBA), and is accompanied by the Caregiver–teacher rating form (C-TRF; Achenbach, 
2009). The CBCL is a standardized measure that can be administered in 20 minutes. It assesses a 
child’s psychopathology by examining both internalizing (e.g., anxiety, withdrawn, and 
depressed), and externalizing (e.g., aggression, attention) behaviors as well as language 





comprised of 99 items total, as well as additional descriptor sections allowing informants to 
report any additional concerns or behaviors observed.  
 Separate factor analyses for both the CBCL and the C-TRF have identified a total of 
seven factors for the CBCL (i.e., Emotionally Reactive, Anxious/Depressed, Aggressive 
Behavior, Attention Problems, Somatic Complaints, Withdrawn, and Sleep problems) while the 
latter excludes the “sleep problems syndrome” for a total of six factors (Liu, Cheng, & Leung, 
2011). Also included in the scoring of the CBCL and C-TRF are five DSM-oriented scales: 
Affective Problems, Anxiety Problems, Pervasive Developmental Problems, Attention 
Deficit/Hyperactivity Problems, and Oppositional Defiant Problems (Achenbach & Rescorla, 
2000). Statistical analysis of test-retest reliability identified an average correlation of .85 for the 
CBCL and an average correlation of .81 for C-TRF (Rescorla, 2005). However, a limitation of 
their paper was the failure to offer specialized norms on the CBCL for the ASD population. 
Baby and Infant Screen for Children with aUtIsm Traits 
 To address both the need for early identification, and better account for the unique 
presentation occurring in the ASD population an informant-based measure, the BISCUIT was 
created (Matson et al., 2007). The BISCUIT assessment battery is composed of three parts and is 
designed to assess infants and toddlers aged 17 to 37 months. Item selection was based upon the 
methodology of scale development outlined by Crocker and Aligna (1986), and DeVellis (1991). 
BISCUIT-Part 1 was created as a diagnostic tool for assessing infants and toddlers for either AD 
or PDD-NOS. The BISCUIT-Part 2 is the primary focus of the present article, and measures 
symptoms associated with concomitant mental health disorders (e.g., ADHD, obsessive-
compulsive disorder, tic disorders, and specific phobias). Lastly, BISCUIT-Part 3 assesses for 





BISCUIT-Part 2 contains 65 items that are rated based upon the extent to which they 
have been the source of recent impairment as follows: 0, “not a problem or impairment”; 1, 
“mild problem or impairment”; 2, “severe problem or impairment”; or X, “does not apply or 
don’t know” (Matson et al., 2008). Ratings of impairment/occurrence are accumulated and then 
mapped onto five different subscales: ADHD, tic disorder, obsessive-compulsive disorder, 
specific phobia, and eating/feeding difficulties. Matson, Boisjoli, Hess, and Wilkins (2011) 
found the BISCUIT-Part 2  to have excellent internal consistency with alpha levels exceeding 






Significant research has been published highlighting the increased occurrence of 
comorbid psychopathological conditions in toddlers with ASDs when compared to both typically 
and atypically developing peers (Barthélémy et al., 1992; Dawson, Matson, & Cherry, 1998; 
Gadow, DeVincent, Pomeroy, & Azizian, 2004; Holden & Gitlesen, 2007; Horner, Carr, Strain, 
Todd, & Reed, 2002; Matson et al., 2010; Matson & Nebel-Schwalm, 2007; Matson & Rivet, 
2008; Paclawskyj, Matson, Bamburg, & Baglio 1997). Comorbid psychopathology in toddlers 
with ASD complicates not only differential diagnosis and intervention approaches, but also 
negatively impacts caregivers and the individual’s prognosis (Gray, Ansell, Baird, & Parr 2011; 
Matson & Minshawi, 2007; Matson & Nebel-Schwalm, 2007). However, research has failed to 
extend beyond prevalence rates to investigate the topography of comorbid symptoms in toddlers. 
An increased knowledge concerning the topography of comorbid psychopathologies in toddlers 
with ASDs is imperative to increase the knowledge of symptom manifestation, common 
behavioral presentations within this population, and the trajectory and stability of symptoms. 
This knowledge can inform multiple domains, including assessment, treatment, and etiology 
(Matson et al., 1996; Matson & Bamburg, 1998; Matson, Hess, & Boisjoli, 2010).  
The importance and success of early intervention approaches in the ASD population has 
been recognized by many researchers (Peters-Scheffer, Didden, Korzilius, & Matson, 2012; 
Peters-Scheffer, Didden, Korzilius, & Sturmey, 2011; Poustka, Rothermel, Banaschewski, & 
Kamp-Becker, 2012; Reichow, 2012).  Additionally, LoVullo and Matson (2009) identified the 
need for highly individualized interventions when comorbid symptoms are present in toddlers 
with ASD. However, these intervention techniques can only be beneficial when behavioral and 





these interventions occur before the implementation of other interventions (e.g., educational) can 
be expected to be fruitful. However, there is a scarcity of comorbid psychopathology research 
available in toddlers, who have been identified as the benefactors of early interventions (Matson 
et al., 2010).  
Researchers have only just recently begun to extend the investigation of comorbid 
symptoms to infants and toddlers. The current paper served as a means of further analysis of 
developmental psychopathology.  In order to assess for any comorbid psychopathology 
symptoms the BISCUIT-Part 2 was administered to parents of infants and toddlers (17-37 
months of age) with diagnoses of AD, PDD-NOS, or atypical development. The purpose of the 
current study was primarily to investigate the expression of comorbid psychopathological 
symptoms in an infant ASD population when compared to their atypically developing peers 
without an ASD. Temporal influences on the expression of comorbid psychopathology 
symptoms were also evaluated. The current research is important for enhancing the 
understanding of the relationship between ASDs and comorbid psychopathology manifestation 
during the early stages of development.  
The stability of core symptoms in individuals with AD has been replicated in multiple 
studies (Landa et al., 2007; Werner et al., 2005). Additionally, reliable early identification of 
ASD has been linked to the presence of more severe symptoms found in toddlers with AD 
(Matson & Horovitz, 2010). However, research investigating the manifestation of comorbid 
psychopathology in infants is sparse. Investigation of developmental psychopathology in an 
infantile and toddler populace with an ASD diagnosis is to the extent of this researcher’s 





 It is hypothesized that comorbid psychopathology symptoms will be moderately stable in 
all participants belonging to the AD and atypical development categories. A perfect replication 
of scores from the first administration to the second cannot be anticipated due to the informant-
based nature of the measure and testing familiarity associated with multiple administrations of 
the same assessment. A significant amount of instability, however, is expected for the PDD-NOS 
group due to the lack of specified criteria provided by the DSM-IV-TR for this diagnosis.  
Furthermore, researchers have suggested concern surrounding the instability of the PDD-NOS 
diagnosis itself in an infantile population (Stone et al., 1999, Worley et al., 2011). The 
identification of symptom instability should not deter the assessment of individuals with a PDD-
NOS diagnosis. Rather, it should educate and prepare clinicians by identifying the need for 
periodic reassessment to evaluate the intervention’s accuracy. Investigation of the temporal 









  Participants in the current study consisted of 315 infants and toddlers who had received 
services provided by the state of Louisiana’s EarlySteps program. Louisiana’s Individuals with 
Disabilities Education Act, Part C (2004) created EarlySteps, a program within Louisiana’s Early 
Intervention System providing services to children and their families. In order to qualify for 
services, children must have been identified as having a developmental delay or a medical 
condition that places them as at risk for a developmental delay and fall within a specified age 
range (i.e., birth to 36 months).  
Following their participation in the EarlySteps program, individuals were separated into 
one of three groups dependent upon their clinical diagnosis (i.e., AD, PDD-NOS, or atypical 
development without an ASD).  Diagnoses for an ASD were made in accordance with the criteria 
outlined by the DSM-IV-TR by a licensed clinical psychologist. Diagnostic decisions were made 
by reviewing the descriptors provided in the DSM-IV-TR for PDD-NOS (APA, 2000), the DSM-
IV-TR algorithm for AD, the individual’s scores on the BDI-2 (Newborg, 2005), and M-CHAT 
scores (Robins et al., 2001). Participants were identified as atypically developing based upon a 
failure to meet developmental milestones or the presence of genetic disorders (e.g., Down's 
syndrome) or physical disabilities. The clinician assigning the diagnoses was a licensed 
psychologist with more than 30 years of experience within the developmental disabilities field. 
During the reviewing and subsequent diagnosis of cases, the clinician was blind to results from 
the BISCUIT assessment. Initially, a total of 315 individuals were identified from a large dataset 
who received two administrations of the BISCUIT-Part 2 and were within the identified age 





and length of time between initial and follow-up administration were examined. Participants 
were excluded from the study if adequate information was not included in the database (e.g., 
incomplete measures), if they did not retain their initial diagnosis, or if they received a follow-up 
assessment in fewer than four months, or after 13 months. The final sample consisted of 205 
toddlers (see Table 1 for demographic information).  The sample was divided into three groups 
based upon diagnosis: AD (n=35); PDD-NOS (n=32); or atypically developing (n=138).   
Participants in each diagnostic category were also separated into two temporal groups for 
further analysis, Time1 (AD n=20; PDD-NOS n=17; atypical development; n=72) or Time2 (AD 
n=15; PDD-NOS n=15; or atypical development n=66). Additional information was also 
gathered from the database (i.e., demographics [ethnicity and gender] and assessment 
information [developmental quotient]). A preliminary Chi-square analysis was then used to 
determine if significant differences in demographic variables (i.e., ethnicity or gender) and 
assessment information between the diagnostic groups was evident. Demographic characteristics 




                                                 AD                 PDD-NOS             Atypical                 Total Sample 
Age in months (SD)           23.51 (4.1)     23.09 (3.84)       23.24 (3.84)         23.26 (3.86) 
Gender 
 Male   77.1%       78.1%                 78.3%              78% 
 Female  22.9%       21.9%         21.7%              22% 
Ethnicity 
 Caucasian  45.7%       43.8%         41.3%              48.3% 
 African-American 45.7%       43.8%         50.0%              42.4% 
 Hispanic    5.7%         0%           5.8%                4.9% 
 Other/Unspecified   2.9%       12.4%           2.9%                4.4% 
Diagnostic percentage 17.1%       15.6%          67.3%  
Developmental Quotient  72 (13.38)      80.56 (14.23)      86.77 (11.44)       83.67 (13.22) 
Note: SD = Standard Deviation, AD = Autistic Disorder, PDD-NOS = Pervasive Developmental 







    
Measure 
Baby and Infant Screen for Children with aUtIsm Traits-Part 2 (BISCUIT-Part 2; 
Matson et al., 2007). Researchers have suggested that the manifestation and expression of 
comorbid psychopathological symptoms within ASDs are unique and different from the 
presentation seen in other disorders (Matson et al., 2007). While assessment measures such as 
the BASC-2 and CBCL screen for the presence of comorbid psychopathology, these measures are 
not designed to account for the unique presentation witnessed in an ASD population.  The 
development of the BISCUIT-Part 2 to assess for comorbid psychopathologies has filled this gap 
(Matson et al., 2009).     
The BISCUIT-Part 2 is a singular component of a triad of informant based measures (i.e., 
BISCUIT-Parts 1-3) falling under the general battery developed to specifically screen for the 
presence of ASD symptomology, comorbid psychopathology, and challenging behaviors in 
infants and toddlers within the 17 to 37 month old age range (Matson et al., 2009). The 
BISCUIT-Part 2 contains 65 items that respondents endorse on a 4-point Likert scale based upon 
the extent that the item has been a recent problem as follows: 0, “not a problem or impairment, 
not at all”; 1, “mild problem or impairment”; 2, “severe problem or impairment”; or X, “does not 
apply or don’t know” (Matson et al., 2008). The BISCUIT-Part 2 is designed to assess for 
symptoms associated with the following comorbid psychopathological disorders: ADHD, tic 
disorder, obsessive-compulsive disorder, specific phobia, and eating/feeding difficulties (Matson 
et al., 2009). An exploratory factor analysis identified five factors and led to the creation of the 
following subscales: Tantrum/Conduct Behavior, Inattention/Impulsivity, Avoidance Behavior, 
Anxiety/Repetitive Behavior, and Eat/Sleep Problems (Matson et al., 2011). When assessing 





reliability with an alpha level of .96, which is indicated as ideal in the literature (Clark & 
Watson, 1995). The cutoffs for the BISCUIT-Part 2 are different and based upon the toddlers 
diagnosis (i.e., ASD or atypically developing) and are further separated by score into one of three 
sections, No/Minimal Impairment, Moderate Impairment, and Severe Impairment.  
See Table 2 for an indication of how the BISCUIT-Part 2 scores correspond with their 
respective levels of impairment unique to each subscale in the ASD population. See Table 3 to 
determine how the BISCUIT-Part 2 scores correspond with their respective levels of impairment 
unique to each subscale in the atypically developing population. 
Table 2 
Severity levels in ASDs 
_____________________________________________________________________________________  
__________________________No/Minimal Impairment      Moderate Impairment       Severe Impairment 
Tantrum/Conduct Behavior                   0 to 16      17 to 24         25 and up 
Inattention/Impulsivity                          0 to 15      16 to 22          23 and up 
Avoidance Behavior             0 to 6         7 to 10          11 and up 
Anxiety/Repetitive Behavior             0 to 6        7 to 9          10 and up 
Eat/Sleep Problems             0 to 3         4 to 5            6 and up 
  
Table 3  
Severity levels in atypical development without an ASD 
_____________________________________________________________________________________  
__________________________No/Minimal Impairment      Moderate Impairment       Severe Impairment 
Tantrum/Conduct Behavior                   0 to 6      7 to 10       11 and up 
Inattention/Impulsivity                          0 to 5      6 to 9         10 and up 
Avoidance Behavior             0 to 1       1 to 2           3 and up 
Anxiety/Repetitive Behavior             0 to 1      1 to 2           3 and up 
Eat/Sleep Problems             0 to 1      2 to 3             4 and up 
 
Procedure 
Following referral to Louisiana’s EarlySteps program, the BISCUIT assessment battery 
was administered to a parent/caregiver in addition to a comprehensive package of assessments to 





to the same informant in the presence of the at-risk toddler twice with no less than three months, 
but no more than one year separating the initial and follow-up administration. Assessments were 
administered by evaluators employed by the EarlySteps program with a minimum of a bachelor’s 
degree, but ranging up to a doctoral degree. The variance of educational attainment is further 
complemented by assorted certifications and licenses representative of their respective 
disciplines (e.g., psychology, education, social work, speech/language pathology, and early 
childhood development). In addition to their educational background, each evaluator received 
training in standardized assessment administration methods, and training specific to the measures 
being administered.  Approval of both the state of Louisiana’s Office for Citizens with 
Developmental Disabilities and the Louisiana State University Institutional Review Board was 
obtained prior to the utilization of the demographic and diagnostic information. Parental consent 
was given at the time of assessment. The data obtained from these interviews was coded and 






An a priori power analysis was carried out utilizing a statistical software package 
identified as GPower*3 (Faul, Erdfelder, & Buchner, 2007) to determine the sensitivity of the 
factorial multivariate analysis of variance (MANOVA) with a conservative harmonic mean. In 
an effort to satisfy the standards provided by Cohen (1992) a desired power level of .80 was 
selected along with an alpha (α) set at a significance level of .05 to determine the effect size 
given the conservative harmonic mean sample size included. The parameters outlined above are 
considered by Hinkle, Wiersma, and Jurs (2003) to be ideal in behavioral science research. 
Given a conservative harmonic mean sample size (n = 45) an effect size of .20 would have an 
achieved power of .80, an effect size of .25 would equate to an achieved power of .90, and an 
effect size of .50 would have an achieved power of .99.  
Prior to statistical analyses, both of the administrations of BISCUIT Part-2  were 
reviewed to ensure that there were no missing item responses and that item values were valid 
(i.e., 0, 1, or 2).  Participants found to be missing more than 10% of responses for any subscale 
for each administration of the BISCUIT Part-2 were excluded from the study. For the remaining 
data set, Little's Missing Completely At Random test (MCAR; Little, 1988) was run to ensure 
that the missing data was missing at random and not predictable from other variables or related 
to the dependent variables or informant omission. The MCAR was not significant, indicating that 
the items were missing completely at random (Tabachnick & Fidell, 2007; Van Ness, Murphy, 
Araujo, Pisani, & Allore, 2007).  
In order to estimate values for the missing items, the multiple imputation procedure was 
used. The multiple imputation procedure involves multiple steps for estimating missing item 





diagnostic category, time category, developmental quotient, and age as predictor variables. 
Based upon these variables, the logistic regression creates an equation for estimating missing 
item values for each diagnostic category (Tabachnick & Fidell, 2007). In order to identify the 
distribution of variables with missing data, a random sample with replacement is then drawn 
from the cases without missing variables. The identified variable distribution for each missing 
item was then used to provide an estimate for the missing items in five random samples (with 
replacement). The average imputed variable across all five samples for each missing item was 
then included in a sixth dataset for analysis (Mehrotra, Li, Liu, & Lu, 2012; Rubin, 1987). 
Statistical Solutions, Ltd. (1997) suggested that multiple imputations are advantageous for 
within-subjects designs because the procedure retains the sampling variability. 
Researchers have found the MANOVA to be robust to violations of non-normality, when 
ten or more participants are included in each group (Seo, Kanda, & Fujikoshi, 1995). Tabachnick 
and Fidell (2007) suggested that when sample sizes are unequal, a significant result from Box’s 
M test for homogeneity of variance-covariance matrices should be followed by additional 
analyses. For the current analysis, the ratio for any dependent variable for each diagnostic group 
from smallest to largest variance does not exceed the 10:1 (Actual current Fmax =  3.71; 4:1) ratio 
suggested by Tabachnick and Fidell (2007) to invalidate the use of a MANOVA. Further, the 
discrepancy in sample size between diagnostic categories in the current sample is more 
representative of the population distribution (Fmax = 4:1). All statistical analyses were run 
utilizing the SPSS 21.0 software package. 
Preliminary Statistics  
A priori analyses were conducted to investigate potential differences between the three 





developmental quotient, and age (see Table 1).  Results of the chi-square analysis indicated that 
there were no differences in gender (χ2 [2, N = 205] = .02, p = .99) or ethnicity (χ2 [6, N = 205] 
= 7.94, p = .24) among the three groups. Although there was an observed difference in male to 
female ratios in the ASD groups, the gender difference (approximately four times as common in 
males) has been recognized by multiple researchers (Fombonne, 2005; Kanner, 1971).  An 
analysis of variance (ANOVA) was then conducted to test for any statistically significant 
differences in age between diagnostic groups.  Age was examined using Levene’s test, which 
showed that homogeneity of variance was upheld (p = .90).  Results of the ANOVA indicated no 
significant age differences among the three diagnostic groups F (2, 201) = .11, p = .90. 
An additional ANOVA was computed to determine if a statistically significant difference 
existed between groups for the developmental quotient. Only a portion of the participants in the 
current study had a developmental quotient score and could be included in this analysis (AD = 
22, PDD-NOS = 25, Atypical = 108). The ANOVA revealed a significant difference among the 
three groups for developmental quotient, F (2, 152) = 14.36, p < .01; however, due to the 
unequal sample sizes, Hochberg’s GT2 corrected post hoc comparisons were computed (Field, 
2009). Results of this analysis revealed that the difference resulted from significant differences 
between the atypically developing group and the AD group (p < .01), there was not a significant 
difference between the atypically developing and the PDD-NOS groups (p = .07) or the PDD-
NOS and AD groups (p = .06). Due to the observed differences in developmental quotient among 
diagnostic categories this variable will not be entered as a covariate (Field, 2009).  
A Kolmogorov-Smirnov test was then conducted for each factor (i.e., diagnostic category 
and time) to test if the dataset was normally distributed.  The result of this test of normality was 





plots were also reviewed during tests of normality, and a positively skewed distribution was 
observed. However, Field (2009) identified that when large samples are used, the Kolmogorov-
Smirnov test can be significant even when scores vary slightly from a normal distribution. Field 
(2009) additionally identified that due to the problem of small standard errors when a large 
sample (n > 200) is used, no criterion for skewness and kurtosis should be applied. 
In order to investigate the stability of comorbid psychopathological symptoms across 
diagnostic groups, participants were first separated into their respective diagnostic categories 
dependent upon diagnosis received following their participation in the EarlySteps program (i.e., 
AD, PDD-NOS, or atypically developing). The diagnosis being utilized was based upon the 
methodology outlined in the contents of the participant section above. The difference between 
each individual’s achieved score across both administrations of the BISCUIT-Part 2 for each of 
the five factors was then computed. An absolute difference score between initial and follow-up 
assessment was then computed for each factor and represents the amount of change for each 
factor among the three diagnostic groups. Due to the desire to measure any change in symptoms, 
the absolute difference score ignored directionality (i.e., increased item endorsement, or 
decreased item endorsement). Utilizing this classification system, the stability of symptom 
expression was then examined based upon observed changes in item endorsement between two 
assessments.  
The time lapse between successive administrations was also examined. In order to 
thoroughly investigate the influence of temporal factors on symptom stability, a two-part 
classification system was created. Participants were segregated into two groups dependent upon 
the time span separating their initial and follow-up evaluation.  Participants with a span of 4 to 8 





the second group consisted of participants whose follow-up assessments were conducted 9 to 13 
months (i.e., Time2) after initial evaluation. The ranges expressed here are centered upon the 
EarlySteps programs attempt to reassess individuals at six month intervals (e.g., 6 months, and 
12 months). 
Study 
A 3 X 2 factorial between-subjects MANOVA was computed to assess whether there are 
significant changes in item endorsement based upon diagnosis (i.e., AD, PDD-NOS, and atypical 
development) and/or time (i.e., time spans between the initial and follow up evaluation) across 
two administrations of the BISCUIT-Part 2.  The current study contained two independent 
variables. The identified between-subjects factors were, diagnosis (i.e., AD, PDD-NOS, and 
atypical development), and the length of time between the assessments (i.e., 4 to 8 months or 9 to 
13 months).  The dependent variables between-subjects factor were the absolute difference’s 
derived from each participant’s respective BISCUIT-Part 2 scores across both administrations 
for each subscale. Descriptive statistics were run in order to identify the respective mean for each 
temporal group. A series of univariate ANOVAs were computed for each dependent variable 
with Bonferroni corrections to control the inflation of Type I error. Following a significant main 
effect for diagnosis, pairwise comparisons were computed between each respective diagnostic 
category which included all individuals regardless of the time factor. Due to the observed 
differences in sample sizes, Field (2009) recommends that a Gabriel’s procedure will be too 
liberal and instead both Hochberg’s GT2 and Games-Howell procedures be selected for post hoc 
analysis. Finally, the significant MANOVA was followed with a discriminant functional analysis 







Initially, descriptive statistics were computed to look at the mean and standard deviation 
for the absolute difference for each of the five factors of the BISCUIT-Part 2 based upon 
diagnostic category (Table 4).   
Table 4  
Means and standard deviations of the absolute difference factor scores on the BISCUIT Part-2 







 n = 35 n = 32        n = 138 
Factor 1    
   Sleep 2.11 (1.43) 1.00 (1.24)         0.84 (1.10) 
Factor II     
   ADHD  5.63 (4.94) 3.22 (3.53)         2.3 (2.88) 
Factor III    
   Avoidant                   2.51 (2.65) 1.78 (2.56)        0.78 (1.40) 
Factor IV   
   Anxiety  3.80 (2.95)       1.84 (2.30)             1.18 (1.64) 
Factor V 
   Tantrum  6.60 (6.07)        4.78 (5.10)             2.62 (3.11) 
Note: SD = Standard Deviation, AD = Autistic Disorder, PDD-NOS = Pervasive Developmental 
Disorder – Not Otherwise Specified. The absolute difference between the initial and follow-up 
assessment was used to calculate the above values. 
 
A  MANOVA was performed on two independent variables: diagnostic group (i.e., AD, 
PDD-NOS, and Atypical) and time lapse (i.e., Time1 and Time2). There were five dependent 
variables based upon the absolute difference between the two subscale totals of the five factors 
of the BISCUIT-Part 2. A significant Box’s test suggested that homogeneity of variance-
covariance was violated. However, due to the vulnerability of having a significant Box’s test 
when there is a discrepancy in sample size is present, additional analyses were conducted, 
revealing that the assumption was tenable (Fmax = 4:1). Field (2009) suggested the use of 
Pillai’s trace for interpreting the results of a MANOVA when group sizes are different and 





diagnosis on the stability of comorbid symptoms was observed, V = .29, F (10, 392) = 6.54, p < 
.01, partial η2 = .14. Additionally, a significant main effect of Time was also observed, V = .08, 
F (5, 195) = 3.33, p < .05, partial η2 = .08. The interaction between diagnostic category and the 
time between original and follow-up assessment was not found to be significant, V = .08, F (10, 
392) = 1.63, p = .1, partial η2 = .04. The observed interaction between diagnosis and time was 
not significant. The results of the significant MANOVA were indicative of differences among 
the diagnostic categories. The significant main effect for Time indicated that three factors of the 
BISCUIT-Part 2 were significantly different when assessed at a later time period (i.e., Time2; 
Table 5). Specifically, significant differences between Time1 and Time2 were observed for the 
following factors: ADHD F (1, 203) = 4.61, p < .05, partial η2 = .02, Avoidant F (1, 203) = 6.1, 
p < .01, partial η2 = .03, and Tantrum F (1, 203) = 6.19, p < .01, partial η2 = .03. 
Table 5  
Means and standard deviations of factor scores on the BISCUIT Part-2 based upon time between 






 n = 109 n = 96  
Factor 1    
   Sleep   0.10 (1.75) -0.26 (1.56)   
Factor II     
   ADHD  -0.22 (4.17) -2.15 (4.81)  
Factor III    
   Avoidant                   -0.06 (1.88)  -0.64 (2.71)   
Factor IV   
   Anxiety  -0.03 (2.64)        -0.52 (2.99)   
Factor V 
   Tantrum    0.01 (4.88)        -1.70 (6.26) 
Note: SD = Standard Deviation. The absolute difference between the initial and follow-up 
assessment was used to calculate the above values. 
 
The significant main effect for diagnosis observed in the MANOVA was followed up 





ANOVA will be discussed separately. Factor I, Sleep, did not violate any of the assumptions of 
the ANOVA and a significant main effect of diagnosis was observed F (2,202) =16.20, p < .01, 
partial η
2 
= .13. Each of the remaining four factors did violate the homogeneity of variance 
assumption for an ANOVA, and therefore the more robust Welch’s test is reported. Factor II, 
ADHD, indicated a main effect of diagnosis Fw (2, 52.84) = 7.69, p < .01, partial η2 = .13. A 
Welch’s test for Factor III, Avoidant, indicated a main effect of diagnosis Fw (2, 49) = 8.69, p < 
.01, partial η2 = .13.  A Welch’s test Factor IV, Anxiety, indicated a main effect of diagnosis Fw 
(2, 51.15) = 13.24, p < .01, partial η2 = .20. Finally, a Welch’s test for Factor V, Tantrum, also 
indicated a main effect of diagnosis Fw (2, 49.50) = 9.04, p < .01, partial η2 = .14.   
Due to the difference in sample sizes and difference in population variances (Fmax = 
4:1), the Games-Howell procedure was used to control for the inflation of Type I errors when 
running multiple comparisons. The Games-Howell procedure has been identified as the most 
powerful and accurate when sample sizes are not equal (Field, 2009). The post hoc comparisons 
for each of the five factors of the BISCUIT Part-2 were examined separately. Post hoc 
comparisons using the Games-Howell procedure indicated that the mean difference between the 
AD and Atypical groups were significant for each factor (p < .05; Table 6). Additionally, the 
average difference between ASD groups was significant for two factors, Sleep and Anxiety (p < 
.05; Table 6). No significant differences in developmental psychopathology were observed 
between the PDD-NOS and Atypical groups (Table 6).  
The MANOVA was also followed by descriptive statistics to analyze the observed trend 
of change in comorbid symptom expression for each diagnostic category across administrations 






Table 6  
Mean difference between diagnostic groups following Post hoc comparisons using the Games-
Howell procedure 
 AD/PDD-NOS          
M (SD) 
PDD-NOS/Atypical 
    M (SD) 
       AD/Atypical 
     M (SD) 
 n = 35 n = 32        n = 138 
Factor I    
   Sleep 1.11** 0.16          1.27** 
Factor II     
   ADHD  2.41 0.91         3.32** 
Factor III    
   Avoidant                   0.73 1.00         1.73** 
Factor IV   
   Anxiety  1.96*        0.66                   2.62** 
Factor V 
   Tantrum  1.82        2.17                3.98* 
Note: SD = Standard Deviation, AD = Autistic Disorder, PDD-NOS = Pervasive Developmental Disorder 
– Not Otherwise Specified. The absolute difference between the initial and follow-up assessment was 
used to calculate the above values. *significant at the .05 level, **significant at the .01 
 
Table 7  








 n = 35 n = 32        n = 138 
Factor I    
   Sleep   0.57 (2.51) -0.25 (1.58)       -0.19 (1.38) 
Factor II     
   ADHD  -0.94 (7.49) -0.78 (4.74)       -1.25 (3.47) 
Factor III    
   Avoidant                   -0.46 (3.65) -0.97 (2.98)       -0.14 (1.60) 
Factor IV   
   Anxiety  -0.09 (4.85)       -0.47 (2.93)            -0.25 (2.00) 
Factor V 
   Tantrum  -0.77 (9.00)      -1.28 (6.92)            -0.68 (4.00) 
Note: SD = Standard Deviation, AD = Autistic Disorder, PDD-NOS = Pervasive Developmental Disorder 
– Not Otherwise Specified. 
 
Additional post hoc analyses included a discriminant analysis to investigate the 
relationship between the dependent variables and how the dependent variables discriminate the 
diagnostic categories in the current study (Field, 2009). In the current model discriminant 





(canonical R2 = .23), whereas the second function explained 12.3% of the variance (canonical 
R2 = .04). In combination these discriminant functions significantly differentiated the diagnostic 
groups, Λ = .76, χ2 (10) = 61.50, p < .01. However, removing the first function revealed that the 
second function did not significantly differentiate the diagnostic groups, Λ = .96, χ2 (4) = 8.34, p 
= .08. The correlations between outcomes and the identified discriminant functions revealed that 
Anxiety loaded disproportionately higher on the first function and not the second (r = .87 and r = 
-.10 respectively). Similar patterns were observed for the factors Sleep (r = .72 and r = -.33) and 
ADHD (r = .66 and r = -.04). Correlations between the first and second discriminate function 
remained disproportionate but positive for the remaining two dependent variables, Tantrum (r = 
.67 and r = .43) and Avoidant (r = .64 and r = .46). The discriminant function plot (Figure 1.) 
showed that the first function discriminated the AD and PDD-NOS groups from the Atypical 
group, while the second function differentiated the AD and Atypical groups from the PDD-NOS 
group. 
 
Figure 1 Discriminant function plot. This figure depicts the two functions underlying the 






Treating an ASD during infancy has been proven beneficial (Ben-Itzchak et al., 2008; 
Eaves & Ho, 2004; Matson & Smith, 2008; McEachin et al., 1993). Additionally, core symptom 
stability in individuals with AD has been replicated in multiple studies (Landa et al., 2007; 
Werner et al., 2005). However, researchers have not yet expanded this research to include 
symptoms of developmental psychopathology. Researchers have repeatedly reported the higher 
occurrence of comorbid symptoms in the ASD population when compared to their typically and 
atypically developing peers (Gillberg & Billstedt, 2000; Kim, Szatmari, Bryson, Streiner, & 
Wilson, 2000; Matson, Hess, & Boisjoli, 2010; Park et al., 2012; Schreck et al., 2004). Despite 
the observed increase in frequency of occurrence in individuals with an ASD, this topic has 
received minimal empirical research to date (Matson et al., 2010; Matson & Nebel-Schwalm, 
2007). Even less frequent have been investigations of the expression of comorbid symptoms in 
an infantile ASD populace (Angold & Egger, 2004; Matson et al., 2010).   The current study 
sought to explore symptoms of developmental psychopathology in an infantile ASD population 
based upon the BISCUIT-Part 2. Results from the current study indicated that not only are 
symptoms of developmental psychopathology less stable in infants with ASD, but also that the 
time between assessments is a significant factor influencing stability.  
The diagnostic group had more comorbid symptoms than controls. This finding indicates 
that not only are comorbid symptoms more prevalent in infants with ASD (Gillberg & Billstedt, 
2000; Kim et al., 2000; Park et al., 2012; Schreck et al., 2004), but that the prevalence of these 
symptoms increase with age. The current findings are commensurate with researchers who have 
also reported that juveniles and adults with ASDs exhibit significantly increased rates of 





typically developing peers (Horner, Carr, Strain, Todd, & Reed, 2002; Matson et al., 2010; 
Matson & Rivet, 2008). Contrary to these results, some researchers have not reported significant 
differences in comorbidity when comparing ASD and non-ASD populations. Utilizing the 
Autism Spectrum Quotient (AQ; Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley, 2001) 
to identify participants with ASD, Ketelaars and colleagues (2008) did not observe significant 
differences in the expression of comorbid symptoms when compared to non-ASD peers. 
However, The AQ was not developed as a diagnostic measure, and was originally developed to 
screen for autistic symptoms in individuals with normal intellectual functioning (Baron-Cohen, 
Wheelwright, Skinner, Martin, & Clubley, 2001). 
  A significant main effect for time in the current study revealed that the length of time 
between follow up assessments had a medium effect on the expression of comorbid symptoms. 
Post hoc analyses indicated that time had a small, yet significant, effect on the stability of three 
factors (i.e., ADHD, Avoidant, and Tantrum behaviors), but not the remaining two factors (i.e., 
Sleep and Anxiety). Descriptive statistics revealed an increase in behavior exhibition for each 
factor for the Time2 group. The same pattern was not observed in individuals in the Time1 
group. Contrarily, item endorsements for the factors Sleep and Tantrum indicate that there was a 
decrease in these behaviors when follow-up assessment occurred within six to eight months.  
The significant effect of time on developmental psychopathology and the observed 
increase for each of the five factors assessed suggests that the exhibition of comorbid symptoms 
is not static and may increase with time. Symptoms of comorbid psychopathology increased 
across time regardless of primary diagnoses. While two factors (i.e., Sleep and Tantrum) actually 
decreased in Time1, all five factors of the BISCUIT-Part 2 increased in prevalence when 





three factors in the Time2 group, ADHD, Anxiety, and Tantrum (Table 5). While these factors 
were significantly different, only a small time effect was observed. 
 Contrary to my hypothesis, the expression of comorbid symptoms in the PDD-NOS 
group was not significantly different than that seen in the Atypical group for any factor on the 
BISCUIT-Part 2. Individual analyses of the absolute differences between item responses for each 
factor indicated that although symptom expression for infants with PDD-NOS was not 
significantly different, it did reveal an overall increase in symptom expression (Table 4). A large 
effect of diagnosis on developmental psychopathology was observed for each of the five 
BISCUIT-Part 2 factors. These findings are commensurate with previous research by Matson 
and colleagues (2010) who found a significantly higher prevalence of comorbid symptoms in 
ASD toddlers when compared to controls. Multiple comparisons for each of the five factors were 
conducted following significant ANOVAs. Post hoc analyses revealed that symptom stability for 
the factors significantly differed amongst the ASD categories. Specifically, item responses for 
the AD group when compared to the PDD-NOS group significantly differed for two factors (i.e., 
Anxiety and Sleep). Researchers have previously observed significantly higher endorsement of 
anxiety symptoms in AD populations when compared to a PDD-NOS group and control group 
using the BISCUIT-Part 2 (Matson et al., 2010). Similarly, researchers have suggested that AD 
populations exhibit fears and phobias at higher rates than both typical and atypically developing 
peers (Evans et al., 2005; Matson & Love, 1990).  Increased rates of anxiety and repetitive 
behaviors (i.e., tics), have also been observed in ASD populations (Attwood, 1998; Ringman & 
Jankovic, 2000).  Post hoc analysis of item responses revealed a decrease in the expression of 





Sleep was the only factor in the current analysis for which the observed difference 
between the initial and follow up assessment was positive. However, as indicated in Table 7, the 
average difference in item responses for the Anxiety factor within the AD group was nearly 
positive. The difference in expression of anxiety and sleep symptoms among the AD and PDD-
NOS groups cannot be fully understood with this initial analysis. In the future researchers should 
explore the differences amongst these factors in depth.  The remaining factors (i.e., Tantrum, 
Avoidant, and ADHD), did not significantly differ among ASD diagnoses. Ignoring 
directionality, analysis of item responses for each of the five factors of the BISCUIT-Part 2 
across two administrations were significantly less stable for the AD group when compared to the 
atypical group.  
The observed findings suggest that the expression of comorbid symptoms by infants with 
AD is not static and can change across time when compared to atypically developing peers. The 
instability in the AD group identifies the need for reassessment/evaluation across time for this 
group in particular when developing and implementing intervention programs. Regardless of 
diagnosis, an overall increase in developmental psychopathology was observed for each factor of 
the BISCUIT-Part 2 with the exception of Sleep for the AD group. Aside from this specific 
factor, the overall trend observed in the data indicates that the assessment and continuous 
monitoring of developmental psychopathology is important regardless of primary diagnosis. 
Research regarding the manifestation of comorbid symptoms in infants with ASD is paramount 
in developing and implementing proper interventions (Kim et al., 2000).  
The observed outcome of the discriminant analysis indicates that one underlying 
dimension best captures group separation. As exemplified by a discriminant function plot (Figure 





differences among diagnostic groups. This observation directly supports the results of multiple 
post hoc comparisons which revealed significant differences between the AD and Atypical 
groups for each of the five factors and insignificant differences between the ASD groups for 
three of the five factors. The first variate has a strong positive relationship with each of the five 
DV’s, but most notably with Anxiety and Sleep. These two factors were also the only two factors 
that significantly distinguished the AD group from the PDD-NOS group during post-hoc 
multiple comparisons. In direct contrast, the second variate affects Anxiety, Sleep, and ADHD 
differently from Tantrums and Avoidant symptoms. When the canonical variate correlations of 
DV’s are high for one variate and low for another, the high correlations contribute the most to 
group separation (Bargman, 1970). This information suggests that the first variate affects each of 
the BISCUIT-Part 2 subscales in the same manner, whereas the second variate differentiates 
groups on some dimension that affects Anxiety, Sleep, and ADHD differently. When the two 
discriminate functions were compared, only the first function significantly discriminated 
diagnostic group membership. 
In contrast, with the stability of the core ASD symptoms observed in children with AD by 
multiple researchers (Landa et al., 2007; Werner et al., 2005), the current research suggests that 
symptoms of comorbid psychopathology are not stable, and actually increase across time 
regardless of diagnosis. Previous researchers have identified the negative impact of comorbid 
symptoms on individuals with ASDs (Gray, Ansell, Baird, & Parr 2011; Matson & Minshawi, 
2007; Matson & Nebel-Schwalm, 2007). The current findings highlight the importance of the 
continuous monitoring of developmental psychopathology and the need for the development and 





 While behavioral interventions (i.e., EIBI) have been shown to be effective for children 
with an ASD, the presence of other comorbid developmental psychopathology problems requires 
the development of highly individualized interventions (LoVullo & Matson, 2009). Additional 
interventions, such as the use of psychotropic medication in combination with EIBI, may be 
necessary for children with ASD when comorbid disorders are present (LoVullo & Matson, 
2009; Self, Hale, & Crumrine, 2010). Research surrounding the manifestation of comorbid 
symptoms in an infantile ASD population is critical. The presence of comorbid symptoms 
influence diagnostic formulation and the development of treatment plans, which may negatively 
impact not only the individual, but also parental stress (Gray, Ansell, Baird, & Parr 2011; 
Matson & Minshawi, 2007; Matson & Nebel-Schwalm, 2007). While it is not efficacious to 
withhold treatment from those that may benefit from it, it is equally important to understand how 
symptoms, especially comorbid symptoms manifest independent of treatment in order for 
researchers to reliably determine the efficacy of additional interventions. Outcomes of the 
present study suggest that the presence of comorbid symptoms do not simply dissipate as 
children age. Instead, these symptoms become increasingly prevalent and severe. Comparisons 
between the AD, PDD-NOS, and Atypical groups indicated that this increase in or worsening of 
comorbid symptomatology was significantly greater in those infants with AD. These findings 
suggest that intervention for comorbid symptoms in an infantile ASD population is a necessary 
venture, especially infants with AD. While differences between both time groups analyzed where 
only significant for the Time2, an overall positive trend in comorbid symptom expression was 
observed for both groups (Table 5). The findings of the current study also highlight the need for 
consideration of the time between initial and follow-up assessments. They suggest that the 





(2006) reported that half of their children with autism in their study expressed severe tantrums 
after the age of 3. The current findings should be considered in light of the current legislative 
approaches to early autism intervention. The current EarlySteps program only pertains to 
individuals up to 36 months. If participants are identified within the 24-36 month age range (73 
of the participants in the current study) they would likely age out of the program before their 
presentation of comorbid symptoms was fully assessed and certainly before adequate 
interventions for comorbid symptoms were developed and introduced. Additionally, these factors 
likely interfere with the administration of other interventions (I.e., OT, PT), especially if 
challenging behaviors are present. 
The results of this study should be confirmed by research which monitors any change in 
developmental psychopathology over the course of the implementation of highly individualized 
intervention programs. Such research may help to inform the development of future treatment 
approaches. The current findings may also inform the development of diagnostic and assessment 
measures to assist in the early detection and treatment of both ASDs and comorbid 
psychopathologies in toddlers. The results of the current research offer new information 
concerning the manifestation of psychopathology symptoms in toddlers with an ASD. Such 
knowledge contributes to the ongoing efforts to better understand the features and symptoms of 
ASDs, provide valuable information for the assessment of psychopathology in toddlerhood, and 
lead to the development of more efficacious and streamlined treatment approaches for early 
intervention in ASDs. Enhancing our understanding and ability to identify comorbid symptoms 
in infants with ASD remains important. Matson and colleagues (2010) suggested that the course 
of symptoms associated with conduct problems and behavioral challenges may be altered with 





as possible, no effort was made to control group sample size. Future research should utilize equal 
sample sizes and include a typically developing control group. This direct comparison may 
highlight the benefit of interventions for comorbid symptomology in both the ASD and Atypical 
groups. Researchers should continue to identify and include additional factors that may influence 
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